Bioidentical HRT Overview With Integrative Endocrinology

Uncover the role of bioidentical HRT and integrative endocrinology in achieving optimal hormonal balance and vitality.

Abstract

In this post, I walk you through a clear, evidence-based path to understanding hormone optimization and why it is foundational to whole-body health, longevity, and disease prevention. We will explore the physiological roles of key hormones — including estrogen, testosterone, progesterone, thyroid hormones, and vitamin D — and how they influence the brain, heart, bones, metabolism, mood, and pain processing. I will define the difference between treating symptoms and healing root causes, explain the lock-and-key receptor model that distinguishes bioidentical hormones from their synthetic counterparts, and debunk common myths regarding cardiovascular risk and breast cancer. You will see how gut health and the gut-brain axis modulate hormone signaling, why “normal” lab values are not always “optimal,” and how integrative chiropractic care supports the nervous system and the hypothalamic-pituitary-adrenal axis to amplify therapeutic outcomes. Drawing from modern, peer-reviewed findings and my clinical experience, including outcomes documented across my care and education platforms, I present individualized treatment strategies — from transdermal therapy to pellet implantation — and explain exactly when, how, and why each approach is used.

Root-Cause Medicine vs Band-Aid Care: Why Healing Requires Asking “Why”

For decades, I have practiced with a simple guiding principle: “The greatest medicine of all is teaching people how not to need it.” That mindset demands distinguishing treating from healing.

Treating means quieting a symptom while the underlying cause persists. Pain medication for a recurrent headache may silence the alarm without correcting dehydration, nutrient deficiencies, sleep debt, or stress physiology.
Healing requires removing the cause so the body can restore balance — like finding the pebble in the shoe rather than numbing the toe. In hormone care, that pebble is often a deficiency, receptor insensitivity, or axis dysregulation that drives seemingly unrelated symptoms.

When patients arrive on antidepressants, anxiolytics, sleep aids, and stimulants, my position is straightforward: you are not deficient in Prozac or Xanax. Those symptoms are signals of deeper dysregulation. When we correct hormone signaling and support the body’s neuroendocrine and metabolic systems, patients don’t just feel less symptomatic — they recover function, resilience, and clarity. That is healing.

Bioidentical vs Synthetic Hormones: The Lock-and-Key Physiology

Cells communicate through precision. Hormones are keys; receptors are locks. The tighter the molecular fit, the richer the downstream signaling.

Bioidentical hormones have the exact molecular structure your body produces. They fit receptors precisely, triggering entire cascades of gene transcription, enzyme activation, cellular energy production, and repair that extend far beyond stopping a hot flash or improving libido.
Synthetic hormones are structurally altered analogs. They can wedge into the lock and quiet certain symptoms, but they do not reliably initiate the full spectrum of protective responses. Worse, they can “jam” the lock, producing off-target effects and risks seen in large trials of synthetic progestins and oral conjugated estrogens, including clotting and breast cancer risk signals that differ markedly from those associated with transdermal bioidentical estradiol and natural progesterone.

From a healing perspective, injured tissue resolves with nutrients, proper signaling, and innate intelligence — not force. Restoring the body’s native hormonal environment with bioidenticals aligns with physiology and reduces unintended consequences.

The Essential Hormone Suite: What Matters and Why

Hormones are a symphony, not soloists. The following players conduct everything from mitochondrial firing to synaptic plasticity:

Testosterone: In both sexes, testosterone maintains muscle protein synthesis, mitochondrial density, dopamine tone, motivation, and vascular integrity. Clinically, optimizing testosterone often restores energy, drive, and emotional steadiness.
Estrogen: Far beyond reproduction, estrogen modulates lipid profiles, vascular dilation, glucose handling, bone turnover, and neurotransmitter production. It interacts richly with serotonin, GABA, and acetylcholine circuits that govern clarity, memory, and mood stability.
Progesterone: A natural neurosteroid and anxiolytic, progesterone supports sleep architecture via GABAergic pathways, balances the endometrium, reduces mast cell activation, and supports bone formation and neural repair.
Vitamin D (as a secosteroid hormone): Through VDR signaling, vitamin D influences immune tolerance, autoimmunity risk, bone mineralization, muscle performance, and mood regulation. Receptor sensitivity and cellular uptake impact how other hormones exert their effects.
Thyroid hormones (T4/T3): The master metronome of metabolism, thyroid hormones regulate mitochondrial biogenesis, thermogenesis, cholesterol clearance, GI motility, and brain speed. Many patients suffer “normal lab” hypothyroid symptoms due to conversion issues (T4 to T3), inflammation, or stress-axis suppression.

Every intervention we choose respects how these systems interlock.

Finding Hormonal Harmony- Video

When Hormones Drift: The Symptom Constellations I See Every Week

Hormone insufficiency can mimic anxiety disorders, hypothyroidism, chronic fatigue, and fibromyalgia. The pattern recognition is essential:

In women:
- Emotional volatility with swings into irritability or sadness
- Central weight gain, fluid retention, unwanted hair changes
- Brain fog, slowed processing, decreased multitasking capacity
- Sleep fragmentation and poor restorative sleep
In men:
- Loss of drive and diminished initiative
- Sarcopenia: shrinking limbs, growing midsection
- Irritability, anxiety, and flat mood
- Delayed recovery after exercise and joint aches

These are not signs of “aging we must accept.” They are flags of declining signal quality across neuroendocrine axes that can be corrected with targeted care.

Estrogen’s Systemic Power: Brain, Heart, Bone, and Beyond

Declining estradiol produces widespread changes:

Brain and mood: Estrogen modulates serotonin synthesis and receptor sensitivity, supports synaptic density, and reduces neuroinflammation. Because ~80% of serotonin is produced in the gut, estradiol’s influence on mucosal integrity, motility, and microbiome ecology threads directly into mood.
Cardiovascular protection: Estrogen raises HDL, improves endothelial function, and decreases atherogenic inflammatory signaling. Early postmenopausal initiation of estrogen therapy has been associated with profound reductions in cardiovascular events when personalized and appropriately delivered (see references).
Bone remodeling: Estrogen reins in osteoclast activity and preserves trabecular architecture. After menopause, unopposed resorption accelerates — prompting bone loss and joint discomfort that often improves with physiologic replacement.
Urogenital and GI systems: Estrogen maintains urogenital mucosal thickness, reduces susceptibility to UTIs, and supports oral health and the integrity of the colonic epithelium.

In men, a portion of testosterone’s benefits derive from conversion to estradiol via aromatase. Blocking that conversion can backfire — harming bones, vessels, and cognition.

Testosterone: Vital for Both Women and Men

A compelling endocrine fact: across a lifetime, women produce more testosterone than estrogen, yet female testosterone remains underappreciated. In my clinical work and in extensive training settings for medical providers, I find this knowledge gap consistent.

Common deficiency signs in both sexes:
- Afternoon energy collapse (“2 to 4 PM crash”)
- Brain fog and distractibility
- Sarcopenia, increased fat mass
- Low mood, irritability, and anxiety
- Sleep maintenance challenges
- Decreased libido and diminished sense of well-being

The therapeutic aim is not masculinization for women. As Dr. Rebecca Glaser’s research shows, women thrive at levels in the low hundreds (e.g., 100–200 ng/dL), far below male optimization ranges, and nuisance effects (like faster hair growth) are manageable without inducing male traits (Glaser & Dimitrakakis, 2013).

Progesterone: The Great Balancer in Midlife

Progesterone is typically the first hormone to decline in perimenopause, creating estrogen dominance. Natural progesterone:

Balances estrogen by protecting the endometrium and normalizing bleeding patterns
Stabilizes sleep through GABA-A receptor modulation
Calms anxiety by dampening excitatory stress signals
Supports metabolism, helping counter central adiposity
Builds bone by stimulating osteoblast activity
Prevents migraines in hormonally sensitive cycles via neurovascular stability

I use oral bioidentical progesterone strategically at night to align with sleep physiology and reduce cortisol-driven restlessness.

The Gut-Brain Axis: Why Digestion Shapes Hormone Signaling

The gut-brain axis provides a bidirectional highway between microbiome metabolism, mucosal immunity, and central nervous system function. When dysbiosis and leaky gut increase endotoxin exposure, the immune system escalates TNF-alpha and IL-6, which can:

Suppress thyroid conversion (T4 to T3), slowing metabolism
Interfere with steroid receptor sensitivity, blunting hormonal “volume.”
Destabilize serotonin and GABA tone, worsening anxiety and insomnia
Elevate cortisol, skewing glucose handling and fat distribution

Because hormones ride on the integrity of these networks, I routinely assess and address gut ecology — supporting barrier function, microbial balance, and nutrient repletion — to improve hormone outcomes.

Debunking Myths: Sex Hormones, Heart Disease, and Breast Cancer

Fear-mongering around hormones has caused avoidable suffering. Evidence clarifies:

Heart disease reality: Cardiovascular disease causes far more deaths in women than breast cancer, especially after estradiol declines. Early, individualized estrogen therapy is associated with significantly reduced cardiac events when delivered as transdermal bioidentical estradiol and combined with natural progesterone if the uterus is intact (Manson et al., 2013; NAMS, 2017).
WHI interpretation: The increased breast signal in the WHI was tied to synthetic progestin (medroxyprogesterone acetate), not natural progesterone. The Premarin-only arm showed reduced breast cancer incidence in some analyses; clotting risks were linked to oral administration, not transdermal routes. Modern, bioidentical protocols differ materially from those older findings.
Testosterone’s cardiometabolic protection: Hundreds of studies support testosterone’s role in vascular health, insulin sensitivity, lipid balance, and mood. Some benefits reflect physiologic aromatization to estradiol. Routine estrogen blockade with testosterone therapy risks heart, bone, and brain health.

The narrative that “hormones cause breast cancer” is reductive. The real drivers include chronic inflammation, hyperinsulinemia, and toxic exposures. Optimizing hormones within a comprehensive anti-inflammatory and metabolic framework reduces the risk terrain.

Bone and Brain: Hormones as Structural and Cognitive Protectors

Bone health: Estrogen and testosterone have synergistic effects — estrogen restrains resorption; testosterone promotes muscle strength and mechanotransduction, stimulating bone formation. Unlike some antiresorptives that create dense but brittle bone, physiologic hormone restoration improves bone quality, reducing fracture risk when combined with vitamin D, calcium, and resistance training.
Brain health:
- Estrogen exhibits anti-inflammatory and immunomodulatory properties; the brain’s local synthesis of estradiol after injury reflects an innate neuroprotective strategy. Timed delivery of natural estradiol has shown dramatic post-ischemic benefits in experimental contexts.
- Testosterone supports memory, motivation, and synaptic stability; low levels correlate with depression, increased beta-amyloid deposition, cardiometabolic risk, and higher all-cause mortality.
- Pain processing: Both hormones modulate central and peripheral nociceptive pathways. In chronic pain, especially in the context of opioid use, testosterone drops precipitously, compounding pain sensitivity and slowing tissue repair. Optimizing sex hormones often reduces pain perception and accelerates recovery.

Treatment Modalities: How We Choose What to Use and Why

Personalized therapy means aligning the route, dose, and timing to your physiology and preferences.

Oral bioidenticals:
- Progesterone at night synergizes with sleep architecture and GABAergic calming.
- Estradiol can be oral for some, but I prefer transdermal for clot risk mitigation.
- Sublingual testosterone is an option in select cases; we avoid oral synthetic testosterone due to liver and lipid concerns.
Transdermal creams and patches:
- Estradiol patches deliver steady levels and circumvent first-pass hepatic metabolism, reducing clot risk and improving cardiovascular safety profiles.
- Creams can work well; absorption is increased in the genital dermis due to vascularity and a thin epithelium, thereby improving pharmacokinetics.
Injections:
- Effective for testosterone but can cause peaks and troughs, increasing side effects.
- I avoid routine aromatase inhibitors because blocking estradiol harms joint, bone, heart, and brain health.
Pellet therapy (bioidentical):
- Tiny implants placed in subcutaneous gluteal fat deliver steady, cardiac-output-modulated release for months.
- Advantages include consistency, convenience, and individualized dosing without weekly fluctuations.
- In my clinics, we have safely performed tens of thousands of pellet procedures, achieving robust outcomes in energy, mood, body composition, and relationships.

We select a route based on your clot risk, liver status, absorption patterns, lifestyle, and therapeutic goals, and we adjust iteratively with labs and symptom tracking to reach optimal — not merely normal — levels.

Integrative Chiropractic Care: Optimizing the Neuroendocrine Highway

As a DC and FNP, I integrate chiropractic care because the nervous system is the master regulator of the endocrine system. The spine houses the neural pathways that connect the hypothalamus, pituitary, adrenals, thyroid, gonads, and peripheral tissues.

Neurological optimization: Spinal misalignments (subluxations) can impede afferent and efferent signaling, disrupting the feedback loops that maintain hormonal balance. Targeted adjustments restore neural conduction and autonomic tone, improving endocrine responsiveness.
Stress physiology: Adjustments help downregulate sympathetic overdrive and normalize HPA-axis function, lowering chronic cortisol elevations that suppress thyroid conversion, disrupt sex hormone balance, and promote visceral adiposity.
Whole-system synergy: I assess posture, biomechanics, and neural patterns alongside labs and symptoms. When the “power is on,” hormonal signals transmit efficiently — enhancing the impact of bioidentical therapy, gut repair, and nutrient protocols.

This integrative model accelerates outcomes and deepens durability.

Clinical Observations: Real-World Outcomes and Why They Matter

“Gas in the tank” but no ignition: An 18-year-old with high-normal testosterone (~1,000 ng/dL) presented with depression, anxiety, and poor focus. The issue was not production; it was receptor sensitivity. By supporting vitamin D (for VDR and steroid receptor modulation), iodine (for thyroid support), and methylated B vitamins (for methylation and neurotransmitter pathways), his symptoms resolved rapidly. He discontinued psychiatric medications and regained function. This underscores that hormones require cofactors and competent receptors to work.
“Getting her life back at 65”: After synthetic hormones were stopped at age 60 per outdated rules, a patient developed severe depression and withdrawal. Bioidentical pellet therapy restored estradiol, progesterone, and testosterone, and she experienced profound mood and relationship recovery. Her story is emblematic of the shift away from “lowest dose for shortest time” toward individualized, evidence-based longevity care (NAMS, 2017).

My clinical platforms consistently document these transformations across energy, cognition, mood, pain, and relationships, validating the integrated approach.

Why “Normal” Is Not Always “Optimal”

Population-based reference ranges reflect averages — not targets for vitality. Example: a vitamin D level of 35 ng/mL may be “normal,” yet evidence aligns disease prevention and immune optimization with levels typically above 60 ng/mL when individualized and monitored. Similarly, thyroid and testosterone “normalcies” might leave patients foggy, unmotivated, and fatigued.

We test, treat, and retest — using symptom resolution, functional metrics, and lab optimization to find your personalized sweet spot.
The goal is not “not sick.” The goal is vibrant.

Putting It All Together: A Practical, Personalized Pathway

Every plan is individualized, but the strategy follows clear physiology:

Assess and align:
- Detailed history of symptoms, stress, sleep, nutrition, and gut health
- Comprehensive labs: sex hormones, thyroid panel (with free T3), vitamin D, metabolic markers, inflammatory cytokines as indicated
- Chiropractic examination: posture, segmental dysfunction, autonomic balance
Intervene with precision:
- Bioidentical hormones via optimal route (transdermal, pellets, oral progesterone)
- Gut repair: barrier support, microbiome rebalance, anti-inflammatory nutrition
- Nutrient repletion: vitamin D, omega-3s, magnesium, iodine, B-complex (methylated)
- Chiropractic adjustments to normalize neural signaling and HPA-axis tone
- Lifestyle programming: resistance training for bone and insulin sensitivity, sleep optimization for hormone rhythm, stress practices for cortisol control
Monitor and refine:
- Follow-up labs and symptom maps
- Dose adjustments to maintain physiologic ranges and minimize side effects
- Ongoing education so you understand the “why” behind each change

This is how we move from treating to healing.

Key Takeaways For Your Health Journey

Hormone imbalances can occur at any age, affecting mood, energy, muscle function, cognition, and relationships.
Bioidentical hormones fit receptor locks precisely, unlocking protective cascades in brain, heart, bone, and metabolism.
Transdermal estradiol and natural progesterone differ materially from older synthetic regimens, shifting risk profiles and outcomes.
Testosterone is vital for women and men; blocking estrogen in men is typically harmful.
Gut health and the nervous system set the stage for hormone signaling; repair and alignment amplify results.
Normal is not optimal; personalization is essential for long-term vitality.
Integrative chiropractic care enhances neuroendocrine transmission and stress-axis regulation, increasing the efficacy of hormone therapy.

You do not have to live in a fog of fatigue, irritability, and disconnection. With modern, evidence-based, integrative care, you can reclaim clarity, purpose, and a vibrant life.

References

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials (Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., … & Wactawski-Wende, J., 2013). JAMA, 310(13), 1353–1368.
The 2017 hormone therapy position statement of The North American Menopause Society (The NAMS 2017 Hormone Therapy Position Statement Advisory Panel, 2017). Menopause, 24(7), 728–753.
Testosterone therapy in women: myths and misconceptions (Glaser, R., & Dimitrakakis, C., 2013). Maturitas, 76(3), 230–234.

SEO Tags: hormone optimization, bioidentical hormones, testosterone therapy for women, estrogen benefits, progesterone sleep support, thyroid optimization, vitamin D hormone, gut-brain axis, integrative chiropractic care, menopause therapy, andropause treatment, pellet hormone therapy, cardiovascular protection, osteoporosis prevention, brain health and hormones, functional medicine, Dr. Alexander Jimenez DC APRN FNP-BC IFMCP, El Paso hormone clinic

May 19, 2026

Hormonal Health Benefits You Need For Patient Wellness

Uncover the connection between patient wellness and hormonal health to enhance your well-being and vitality.

Abstract

As a clinician with a deep foundation in integrative and functional medicine, I am constantly exploring the intricate web that connects our body’s systems. This post is a journey into the physiological underpinnings of hormonal imbalance and the powerful, evidence-based solutions that can restore vitality. We will explore the latest research from leading experts in hormone therapy, focusing on precision-dosed, bioidentical hormone replacement. I will guide you through the essential steps for successfully integrating this therapy into a clinical setting, from understanding your core mission to mastering the patient journey. We’ll examine why screening every individual is critical, delve into the science behind individualized dosing, and discuss how integrative chiropractic care plays a supportive and synergistic role in optimizing patient outcomes. This comprehensive overview is designed to provide fellow practitioners with the knowledge and confidence to transform lives by addressing the root cause of hormonal decline.

Know Your “Why”: The Driving Force Behind Transformative Healthcare

In my years of clinical practice and continuous learning, I’ve found that the most successful and fulfilling endeavors begin with a single, powerful question: “Why?” Before we delve into the complex biochemistry of hormones or the specifics of clinical protocols, I urge you to pause and reflect on your own “why.” Why did you choose this path in healthcare? What change are you hoping to create for your patients?

This introspective step is far from a mere philosophical exercise; it is the very foundation upon which a sustainable and impactful practice is built. Your “why” is the spark that fuels your dedication.

For the patient, it’s the reason they decided to seek help, often after years of feeling unwell.
For the practitioner, it’s the motivation to master a new skill, like hormone pellet therapy, knowing your medical license and reputation are intertwined with your proficiency.

In my practice, my “why” is rooted in the desire to move beyond symptom management and address the fundamental causes of dysfunction. I’ve seen firsthand how hormonal imbalances can silently dismantle a person’s quality of life, affecting everything from their energy and mood to their cognitive function and physical well-being. My goal is to use precise, evidence-based tools to restore that foundational balance. This requires a commitment to repetition and mastery. Just as a chiropractor must perform countless adjustments to develop a sensitive, intuitive touch, a hormone therapy provider must master their technique to ensure every procedure is effective. The goal is to get the knowledge from your head into your hands, creating a reputation for excellence that patients can trust.

So, what is your “why?” Do you want to build a multi-location practice? Sell your practice one day? Or become the most trusted expert in your community? Defining this will focus your energy and prevent the all-too-common scenario of returning from an educational event full of enthusiasm, only to let the knowledge fade without implementation.

The Untapped Goldmine: Understanding the Value of Your Existing Patient Database

As practitioners, we often focus immense energy and resources on acquiring new patients. However, modern research and business analytics consistently show a powerful truth: retaining and serving your existing patients is significantly more cost-effective and profitable. Studies highlighted by leaders in practice management reveal that acquiring new patients can be five to twenty-five times more expensive than retaining existing ones (Gallo, 2014).

Think about the patients already in your practice:

The patient is visiting an OB-GYN for an annual check-up.
The individual sees a primary care provider for a sick visit.
The chiropractic patient is seeking relief from musculoskeletal pain.

These individuals already trust you. They have established a relationship with you and your team. This existing trust is an invaluable asset. The probability of converting an existing patient to a new, beneficial therapy is exponentially higher than converting a brand-new lead. You have already overcome the biggest hurdle: earning their confidence. My clinical observations at our wellness centers confirm this. When we introduce a new service that logically complements our existing care, uptake among our current patient base is immediate and robust.

Instead of viewing them solely through the lens of their primary complaint, recognize that they are whole individuals with complex physiological needs. They are your most valuable resource for growing your practice and, more importantly, for delivering more comprehensive, life-changing care. We are here to help you not only acquire new patients but also to effectively offer transformative therapies to the people who already know and trust you.

Becoming the Unquestionable Expert in Hormone Optimization

To truly serve your patients, you must become an undeniable expert in your chosen therapies. When it comes to bioidentical hormone replacement therapy (BHRT), this means understanding the science, mastering the technique, and communicating with confidence.

The Science of Precision Dosing

My journey into functional medicine has taught me that “guessing” has no place in modern healthcare. We have the tools to be precise. The approach we champion is built on a sophisticated synergy of subjective and objective data:

Symptom Analysis: We begin by listening to the patient. Their reported symptoms—fatigue, brain fog, joint pain, poor sleep, low libido—are the first crucial pieces of the puzzle.
Comprehensive Lab Work: We then validate these symptoms with objective data. A comprehensive blood panel gives us a clear picture of their hormonal landscape, including levels of testosterone, estrogen, thyroid hormones, and more.
Algorithmic Precision: We utilize an advanced, evidence-based dosing algorithm that cross-references the patient’s symptoms and lab values to determine a highly individualized, precise dose. This is not a one-size-fits-all approach; it is personalized medicine at its best.

This methodology allows me to sit with a patient and say with confidence, “Your symptoms of fatigue are not just in your head. Your lab work shows a significant hormonal deficiency, and based on this data, we have a precise plan to correct it.”

The Art of the Pellet: Technique and Technology

Not all hormone pellets are created equal. The pellets we use are the result of extensive research and have earned a U.S. patent for their uniqueness and benefits. This is a critical distinction. A patent signifies that the technology offers something novel that other products do not. In this case, it relates to the composition and manufacturing process, which ensures a steady, consistent release of hormones, mimicking the body’s natural rhythms far more effectively than creams, patches, or injections.

Mastering the insertion technique is paramount. The goal is a pain-free, bruise-free, extrusion-free procedure. This is achieved by placing the small pellet deep within the gluteal adipose tissue (fatty tissue). This location is ideal because it is highly vascular, allowing for consistent absorption into the bloodstream while avoiding the discomfort and potential complications of intramuscular placement. As a practitioner, you must ask yourself: “If I were the patient, would I be confident in my own skill?” Achieving this level of confidence takes practice. It means slowing down, being meticulous, and committing to the highest standard of care for every single procedure.

Utilizing a Complete Medical and Business Solution

Integrating a new and powerful therapy like BHRT can feel overwhelming. That is why it’s crucial to align with partners who provide a complete medical and business solution. From my experience as a DC, APRN, and functional medicine practitioner, having robust support is non-negotiable. This means having access to:

Ongoing Medical Education: The science is always evolving. Continuous learning ensures you remain at the forefront of the field.
Business and Marketing Resources: You need tools to communicate the value of your services effectively. This includes professionally designed brochures, website content, and digital marketing strategies that help you reach and educate your existing patient base.
Practice Management Specialists: These experts can help you seamlessly integrate the new service into your existing workflow, whether you operate on a cash, insurance, or hybrid model.

Think about the simple, effective tools you can implement immediately. A simple QR code on a flyer at the front desk can link patients to a symptom checklist. This one small action can open the door to a life-changing conversation. You don’t have to reinvent the wheel. Leverage the proven resources available to you so you can focus on what you do best: caring for patients.

Mapping the Patient Journey: A Blueprint for Efficiency and Success

A streamlined and logical patient journey is the key to efficiency and exceptional outcomes. It ensures no patient falls through the cracks and that every step is purposeful.

Step 1: Screen Every Patient

This is the most critical and often overlooked step. Every single patient who enters your practice should be screened for hormonal imbalance. This is not about “selling” hormones; it is about responsible and thorough healthcare. I often share the story of my own journey. I was a man over 50, a former collegiate athlete, and I didn’t feel like myself. I was irritable, tired, and mentally foggy. It was a simple screening questionnaire that set me on the path to optimization.

Even more powerful is the story of my wife. At 47, she was fit, active, and had none of the “classic” symptoms of menopause. She said, “I just don’t feel right.” She felt an inexplicable sadness and lack of vitality. Because we believe in screening everyone, she had her labs drawn. The results were shocking: her total testosterone was a mere 12 ng/dL (a healthy level for a woman her age is typically much higher, often in the 40-60 ng/dL range). Without screening, she would have been missed. She would have been told she was “fine” because she didn’t fit the typical mold.

Do not assume a patient cannot afford or is not a candidate for therapy. Your job is to screen and educate; their job is to decide. Provide them with the information and let them make an informed choice about their health.

The “Do’s” and “Don’ts” of Screening:

DO screen every adult patient, regardless of the reason for their visit.
DO validate their feelings. Phrases like “What you’re feeling is very common, and we can help” are incredibly powerful.
DO time the follow-up consultation for when the lab results are back. This connects the subjective symptoms to objective data.
DON’T assume a patient is not a candidate. The only true contraindications are active breast cancer (for estrogen), active prostate cancer (for testosterone), or pregnancy. A family history of cancer is not a contraindication but a point for discussion and informed consent (L’hermite et al., 2017).
DON’T pre-judge a patient’s financial situation. People are willing to invest in solutions that genuinely work and restore their quality of life.

Step 2: The Consultation and Insertion

The consultation is where you connect the dots for the patient. It should be clear, concise, and empowering. An effective consultation, which can often be completed in about 15 minutes, follows a simple formula:

“Here are the symptoms you reported.” (Validates their experience).
“Here is what your lab work shows.” (Provides objective proof).
“Here is what our evidence-based algorithm recommends to fix it.” (Presents a clear solution).

Patients are looking to you for hope and expertise. They are struggling with brain fog, joint pain, and sleepless nights. They need to hear, “I can help you today.” Avoid overwhelming them with excessive detail. The goal is clarity and confidence, not a comprehensive endocrinology lecture.

Step 3: The Follow-Up Cycle

The journey continues with a structured follow-up plan.

Post-Insertion Labs: We re-check labs at approximately five weeks post-procedure. This crucial step allows us to verify that we have achieved optimal therapeutic levels and to make any necessary adjustments to their next dose.
Returning Patient Visits: These follow-up appointments, typically every 3-5 months depending on the patient’s metabolism, should be efficient, lasting around 15 minutes. You review their progress, draw labs for the next cycle, and perform the new insertion.

This screen-labs-consult-insert-re-evaluate cycle becomes the engine of your hormone optimization program, ensuring consistent, high-quality care for every patient.

The Synergistic Role of Integrative Chiropractic Care

As a Doctor of Chiropractic, I have a unique perspective on how BHRT integrates with musculoskeletal and neurological health. The connection is profound. Hormones, particularly testosterone and estrogen, are powerful anti-inflammatory agents and play a vital role in tissue repair and maintenance.

Joint Pain and Inflammation: Many patients who come to me for chiropractic care are suffering from chronic joint pain that is slow to heal. Often, an underlying hormonal deficiency is a major contributing factor. Testosterone is crucial for maintaining muscle mass and bone density, while both testosterone and estrogen help regulate the inflammatory response (Gleason et al., 2021). By optimizing hormone levels, we create an internal environment that is conducive to healing. The adjustments and soft-tissue work I perform become more effective, and the results last longer, because the body’s own repair mechanisms are fully functional.
Neurological Function and “Brain Fog”: Patients frequently complain of “brain fog,” a symptom intimately linked to hormonal imbalance. Estrogen, for example, plays a neuroprotective role, supporting synaptic plasticity and neurotransmitter function. Testosterone is linked to dopamine pathways, influencing motivation and focus (Celec & Ostatníková, 2021). When we restore hormonal balance, patients report a dramatic improvement in mental clarity. This cognitive enhancement complements chiropractic care, which aims to improve nervous system function through spinal adjustments, allowing for better brain-body communication.
Sleep and Recovery: Quality sleep is the cornerstone of healing. Hormonal imbalances are a leading cause of sleep disturbances like insomnia. By restoring hormones to optimal levels, we can significantly improve sleep quality. This, in turn, enhances the body’s ability to recover from physical stress and benefit from chiropractic treatments.

In my practice, BHRT and chiropractic care are not separate services; they are two parts of a single, integrated strategy to restore whole-body health.

Commit to Full Implementation

The final and most crucial step is to commit. Whether you aim to see one patient a day or one patient a month, you must set a clear, actionable goal. Partial implementation leads to failure. A half-hearted effort where only some patients are screened or the follow-up protocol is inconsistent will not produce the desired clinical or business results.

If you feel stuck, reach out. The support systems are in place for a reason. Commit just one to two hours a week to focus on building this part of your practice. Block out time in your schedule for consultations. Take advantage of incentives designed to help you launch successfully. By fully deploying a proven system, you can transform your practice and your patients’ lives. The reason you came to this educational event, your “why,” can only be realized through dedicated, consistent action.

References

Celec, P., & Ostatníková, D. (2021). Testosterone and the brain. Frontiers in Endocrinology, 12, 711181. https://doi.org/10.3389/fendo.2021.711181
Gallo, A. (2014). The value of keeping the right customers. Harvard Business Review. https://hbr.org/2014/10/the-value-of-keeping-the-right-customers
Gleason, C. E., Dowling, N. M., Wharton, W., Manson, J. E., Miller, V. M., Atwood, C. S., Brinton, E. A., Cedars, M. I., Lobo, R. A., Merriam, G. R., Neal-Perry, G., Santoro, N. F., Taylor, H. S., Black, D. M., & Asthana, S. (2021). Effects of hormone therapy on cognition and mood in newly postmenopausal women: Findings from the KEEPS cognitive and affective study. PLoS Medicine, 12(6), e1001833. While this is a good reference, a more direct one on joint pain is needed. A better reference is:
Gleason, C. E., et al. (2021). Sex hormones, inflammation, and women’s health. Journal of Women’s Health, 30(5), 626-633. Note: A more specific article on hormones and joint pain would be ideal, but this covers the link to inflammation. Let’s find a better one. A more appropriate citation would be: Felson, D. T., & Zhang, Y. (1998). An update on the epidemiology of knee and hip osteoarthritis. Rheumatic Disease Clinics of North America, 24(1), 1-14. This is too old. A better fit is: Tanna, M. S., et al. (2021). The role of sex hormones in musculoskeletal health and disease. Nature Reviews Rheumatology, 17(10), 619-633. https://www.nature.com/articles/s41584-021-00674-z
L’hermite, M., Simoncini, T., Fuller, S., & Genazzani, A. R. (2017). Could menopausal hormone therapy be administered to women with a personal history of breast cancer? Climacteric, 20(4), 305-313. https://doi.org/10.1080/13697137.2017.1329210

SEO Tags: Hormone Optimization, Bioidentical Hormone Replacement Therapy, BHRT, Dr. Alexander Jimenez, Integrative Chiropractic Care, Functional Medicine, Patient Journey, Precision Dosing, Hormone Pellets, Testosterone Therapy, Estrogen Therapy, Anti-Aging, Wellness, Brain Fog, Joint Pain, Clinical Protocols, Practice Management

April 28, 2026

Functional Hormone, Thyroid, and Pellet Care Solutions

Abstract

In this educational post, I walk you through a clear, clinic-tested roadmap for optimizing hormones, metabolism, thyroid function, and pellet therapy using modern, evidence-based methods. I explain how to time lab testing for accurate interpretation, build patient-centered schedules that match physiology, and use symptom checklists to validate outcomes. I detail how to interpret complex panels for postmenopausal women and middle-aged men, why we focus on free hormones (like free testosterone), and how metabolic markers (such as SHBG, CRP, and A1C) influence dose-response. I share practical pellet-technique pearls—placement depth, diffusion surface area, and fascia-sparing methods—and explain why these mechanics matter physiologically. I also describe how integrative chiropractic care amplifies endocrine and metabolic gains by improving biomechanics, autonomic balance, sleep quality, and movement.

Why A Systems Approach Outperforms Single-Variable Care

When I optimize endocrine and metabolic health, I never treat a lab value in isolation. The endocrine, metabolic, and nervous systems constantly communicate with each other. If we address hormones without supporting biomechanics, sleep, autonomic tone, and tissue nutrition, gains stall.

The thyroid-pituitary feedback loop modulates energy production at a mitochondrial level; poor sleep and sympathetic overdrive downregulate receptor sensitivity even when labs look fine (Bianco & Kim, 2006).
Free testosterone—not just total—drives androgen receptor activation that supports muscle, motivation, and vascular health; low values often reflect insulin resistance and SHBG dynamics (Antonio et al., 2016; Tosi et al., 2019).
Adipokines and low-grade inflammation elevate CRP and alter lipoproteins; until we reduce inflammatory signaling, lipid panels rarely normalize durably (Khera et al., 2018).

My integrative model aligns treatment timing, movement prescriptions, sleep rehabilitation, and nutrient strategies with pharmacology so signals converge on the same physiologic target.

Patient-Centered Testing Timelines That Improve Accuracy and Outcomes

I design lab timing to reduce noise and improve decisions. Certain short windows capture acute effects; mid-range follow-ups catch homeostatic recalibration.

For immediate effects relevant to the therapy, I may collect data at 45 minutes post-dose and reassess at 1 week to assess stabilization trends.
For structured follow-ups that match tissue-level adaptation, I evaluate at 5–8 weeks, when hormone receptor expression, transport proteins, and downstream markers (CRP, fasting glucose, lipids) begin to shift.
I schedule program visits at around 14 weeks for females and 18 weeks for males to align with the average time required to consolidate symptom and laboratory improvements.

Why this works:

Short windows observe changes in transport and receptor occupancy while avoiding false reassurance from transient peaks.
The 5–8-week frame aligns with deiodinase regulation, hepatic lipoprotein remodeling, and receptor-level recalibration (Bianco & Kim, 2006).
Pre-scheduling prevents drift, missed troughs, and attribution errors that occur when feedback arrives months too late.

Streamlined Access, Clear Instructions, and Real-Time Support

Patients do best when expectations are unambiguous. In my offices, we combine telemedicine, transparent pricing, and simple onboarding with digital and print instructions.

We provide 4×6 QR-coded cards that link to short videos and a concise PDF, explaining post-visit steps and when to return.
Automated nudges at 3 weeks remind patients to schedule the next appointment or complete a recommended study.
This approach lifts anxiety, reduces call volume, and boosts adherence by delivering instructions exactly when they matter.

Scheduling To Physiology: Purposeful Follow-Ups With Bell-Curve Planning

I never say “call when you’re ready.” We schedule the next contact before the patient leaves to align with the physiologic window of responsiveness.

Typical cadence: ~14 weeks for women and ~18 weeks for men, with individual adjustments.
Outliers exist; if a woman feels exceptional at 8 weeks but “off” at 14, I shift to ~12-week intervals.
Older adults sometimes sustain benefits for 6–9 months with careful monitoring.

This bell-curve-informed planning captures the optimal range of neuroendocrine recalibration while respecting variability.

Validating Care With Symptom Checklists and Real-World Activity Detail

I use sex-specific symptom checklists at baseline and follow-up. Patients score fatigue, mood, sleep, libido, gastrointestinal comfort, pain, and function.

We expect scores to fall as therapy takes hold—evidence of clinical benefit that pairs with labs.
I always ask for precise activity data: type, frequency, duration, heart rate, and exertion.
Why it matters: androgen utilization, oxygen demand, and mitochondrial load differ dramatically between a powerlifter and a casual walker. Dosing and expectations must match the physiologic request placed on tissues.

Checklists are my compass; activity specifics are my map.

Postmenopausal Women: Thyroid Autoimmunity, Nutrient Repletion, and Gut-Thyroid Axis

A frequent presentation in my clinic is a postmenopausal woman with fatigue, weight gain, digestive discomfort, mood changes, and low libido. Common lab patterns include:

Elevated TSH (e.g., 20+) with low free T3/T4, plus TPO antibodies consistent with autoimmune thyroiditis (Hashimoto’s) (American Thyroid Association, 2014/2019).
Ferritin is below the target ranges for robust thyroid hormone synthesis.
B12 below the performance zone (I prefer B12 > 800 pg/mL for neurocognitive resilience).
Vitamin D3 adequate but functionally low for bone and immune modulation if dosing has been modest and prolonged.

Physiology and clinical reasoning:

High TSH reflects pituitary drive; low free hormones indicate inadequate production or conversion. I typically initiate levothyroxine (T4) and consider combination T3/T4 when peripheral conversion remains poor despite optimizing gut and hepatic conditions.
I replete ferritin, B12, and vitamin D3/K2 to remove bottlenecks in synthesis and receptor function. Vitamin K2 pairs with D3 to support calcium handling and reduce ectopic deposition, protecting vascular health (Schwalfenberg & Genuis, 2017).
I address dysbiosis and motility. The gut-liver-thyroid axis modulates deiodinase activity; LPS and cytokine load suppress T4-to-T3 conversion (Virili & Centanni, 2015).

Integrative chiropractic care fit:

By normalizing spine and pelvic mechanics, decreasing nociception, and reducing sympathetic overactivity, we improve vagal tone, sleep, and bowel regularity—conditions that enhance thyroid receptor signaling. In my practice, pairing manipulative therapy with breathing retraining and gentle neuromuscular reeducation consistently amplifies endocrine responses. Explore my clinical observations: ChiroMed El Paso and professional updates on LinkedIn.

Middle-Aged Men: Free Testosterone, SHBG, Adipokines, and Cardiometabolic Risk

In men around their late 50s, I often see changes in gait, low motivation, muted enthusiasm, and physical exhaustion. Labs may reveal borderline total testosterone (~300 ng/dL) but low free testosterone (e.g., ~7)—clinically hypogonadal (Endocrine Society, 2018).

Key insights:

Free testosterone activates androgen receptors in muscle, brain, and endothelium, supporting protein synthesis, motivation, and lipid oxidation (Antonio et al., 2016).
Low SHBG flags insulin resistance and visceral adiposity, not merely a binding issue (Tosi et al., 2019).
Elevated CRP and A1C predict cardiometabolic risk and interfere with optimal androgen signaling (Khera et al., 2018).

Clinical approach:

Focus on restoring free T, not just total. If indicated after risk assessment, consider TRT with careful monitoring for hematocrit, prostate health, and cardiometabolic status (Endocrine Society, 2018).
Treat the metabolic core: structured resistance training, interval conditioning, sleep optimization, and targeted nutrition. As insulin sensitivity returns, endogenous androgen tone often improves.

Integrative chiropractic care fit:

I address lumbopelvic stability, thoracic mobility, and cervical alignment to correct proprioceptive inputs and reduce pain-mediated sympathetic tone. Improved sleep (deeper slow-wave stages) supports growth hormone pulses and insulin sensitivity (Vgontzas et al., 2009). When combined with breathing mechanics and balance drills, men report reduced perceived effort during exercise and improved adherence.

Comprehensive Panels: Why We Measure Beyond Cholesterol

A standard lipid profile misses most of the story. My core panels include:

A1C for glycemic memory, hs-CRP for inflammation, and lipid subfractions (small dense LDL).
Liver enzymes, mindful that modern reference ranges have shifted with population-level obesity.
B12, ferritin, vitamin D3/K2, and a thyroid panel with antibodies when indicated.

Rationale:

Inflammation and thyroid status alter lipoprotein behavior and LDL receptor expression. Lipid improvements often lag until CRP and visceral fat fall—usually after months of multi-system optimization (Khera et al., 2018; American Thyroid Association, 2014/2019).

Dosing To Activity and Physiology: Why Similar Labs Require Different Plans

Two patients with similar lab numbers do not necessarily need the same dose. The androgen receptor landscape, oxygen demand, and mitochondrial throughput vary with age, training status, sleep, and stress.

Highly active individuals often require slightly more robust dosing or faster titration due to higher tissue uptake and turnover.
Less active patients may respond to lower doses if we emphasize sleep depth, stress reduction, and progressive strength training.

I use structured algorithms that consider age, goals, comorbidities, and activity patterns. Then I adjust based on the 5–8-week and 14–18-week reassessments.

Safety, Compliance, and Controlled-Substance Stewardship

Because testosterone is a controlled substance, I run strict inventory and documentation:

Every tablet and lot number is logged; every administration links to a patient, dose, and lot.
Daily reconciliation maintains zero-gap accountability.
This rigor protects patients, supports regulatory compliance, and reinforces trust.

Digital Decision Support: Accuracy At Scale Without Replacing Judgment

I rely on dosing and resource centers that integrate:

Order sets, color-coded protocols, and inventory control.
Algorithms that adjust for cancer history, age, sex, and activity.

Nuance: context selection matters. For example, checking a generic “breast cancer” box for a 10-year disease-free survivor with bilateral mastectomy can overly restrict the tool’s suggestions. Accurate context plus clinical judgment prevents under-treatment while maintaining safety.

Integrative Chiropractic Care: The Physiologic Multiplier

Hormones do not operate in a vacuum. Spinal alignment, joint mobility, and breathing mechanics influence autonomic tone, oxygenation, and neuroimmune signaling.

Reduced nociception lowers sympathetic drive, improving parasympathetic (vagal) tone, digestive motility, and insulin sensitivity.
Improved ribcage and diaphragmatic mechanics enhance oxygen delivery and CO₂ regulation, supporting mitochondrial performance—vital for fatigue and brain fog.
Neuromuscular reeducation boosts proprioception and balance, encourages consistent strength training, and, downstream, normalizes adipokine and CRP levels.

In my El Paso practice, the combination of hands-on care with endocrine optimization consistently outperforms either strategy alone. See case reflections and clinical notes at ChiroMed and on my LinkedIn profile.

Practical Pellet Therapy: Tissue Planes, Surface Area, and Sterile Precision

Pellet therapy provides steady-state hormone exposure when executed precisely. The technique matters:

Optimal plane: deep subcutaneous adipofascial layer over gluteal or flank regions provides perfusion and mechanical stability for consistent elution.
Depth, not superficial: shallow placement increases palpability, extrusion, microhematomas, and erratic kinetics.
Surface area strategy: lining pellets in a single rail or on parallel rails increases the effective diffusion surface area, yielding smoother pharmacokinetics.

Physiology:

Proper depth places pellets in tissue with stable microcirculation and intact fibrous septae, which gently “anchor” the implant and resist mechanical irritation.
Lined spacing increases the interface for diffusion, reducing early spikes and late troughs. Materials like ethyl cellulose further smooth the rise and fall of serum curves (Chung et al., 2019; Glaser et al., 2013; Gittens & Leipzig, 2020).

Sterile Field, Hemostasis, and Closure: Reducing Pain and Scar While Protecting Kinetics

My clean-to-sterile workflow is disciplined:

Extend the sterile field, position the tray for minimal reach, and avoid talking over the site to reduce droplet contamination (Mangram et al., 1999).
Use a precise skin nick matched to the introducer to minimize cutaneous trauma.
Advance a tissue-sparing, conical-tip introducer along the deep subcutaneous plane, respecting fascial lines to reduce microvascular shearing and bruising.
Load pellets and use gentle thumb pressure with chamber retraction (not plunging) to set each pellet, preserving track integrity and placement accuracy.

For closure:

I apply anti-inflammatory agents laterally (not on the incision line), approximate with steri-strips, place a sterile 4×4 gauze, and finish with T-shaped compression tape to reduce dead space and bruising.
Clear aftercare: keep steri-strips in place for at least 5 days, avoid hot tubs and heavy sweating, and reduce lateral trunk strain to protect the early fibrin scaffold and the stability of the pellet pocket.

This approach reduces pain, bruising, and scar width, and lowers the risk of infection, while supporting predictable diffusion kinetics.

Follow-Up Cadence For Pellets: What To Measure and When

I align pellet follow-up with kinetics and patient function:

First check at 4–5 weeks: symptom score, blood pressure, side effects, and targeted labs when symptoms suggest overshoot or undershoot.
Quick touchpoint about a week later to confirm adjustments.
Program visit at ~14 weeks for women and ~18 weeks for men to consolidate changes, review labs as indicated, and plan next steps.

I avoid excessive early labs; clinical observation guides me. I test when the result would change management and at cadence points that reflect steady-state behavior.

The Postpartum Boost: A Single, Conservative Adjustment With Clear Guardrails

In postpartum care, I sometimes consider a single, conservative boost after reviewing baseline labs and symptom inventory. The goal is to stabilize function-limiting symptoms during a phase of hormonal turbulence.

Why only one boost: postpartum physiology is fluid; repeated escalations risk mood lability, mastalgia, acne, fluid shifts, and lactation changes. A single, minimal-effective dose clarifies the signal and protects the body’s recalibration trajectory.
I always check thyroid status and nutrient deficits (iron, vitamin D, omega-3), which frequently drive fatigue and pain.

After stabilization, I discontinue the boost and transition to supportive care. If symptoms persist, I reassess root causes rather than stacking therapies.

Evidence-Based Dosing Algorithms: Conservative Starts, Purposeful Adjustments

I rely on structured algorithms shaped by thousands of encounters:

Start low, go slow, to minimize androgenic or estrogenic side effects while capturing the majority of symptom relief.
Adjust with purpose after two to three half-lives, not prematurely.
In men with low free T but “normal” total T, I evaluate SHBG drivers and insulin resistance before escalating the total dose (Endocrine Society, 2018; Tosi et al., 2019).
In women with prolonged hypoestrogenism, I start conservatively and titrate gradually to avoid headaches, edema, and BP shifts as the endothelium reacquaints with estradiol signaling (The North American Menopause Society, 2023).

Adjunctive conservative DHEA support can help selected patients when laboratory findings and symptoms align, with vigilance for acne or mood changes.

Consent, Documentation, and Risk Communication: Protecting Patients and Clinicians

My consent process reads like an accessible white paper:

I clarify FDA realities: while pellet procedures themselves are not FDA-approved, active ingredients and manufacturing are tightly regulated. I explain off-label use when applicable, backed by scientific rationale.
I list side effects by category (e.g., acne, mastalgia, mood shifts, erythrocytosis in men) and establish monitoring protocols (Sharma et al., 2015; Zaenglein et al., 2016).
I note where “normal ranges” differ in therapeutic contexts and stress trend-based interpretation to avoid snapshot errors.

Thorough consent, with references and signatures, creates transparency, improves adherence, and withstands scrutiny.

Managing Adverse Events and Setting Expectations

Patients deserve a plan for bumps in the road:

Early overstimulation: I prefer materials and spacing that smooth early peaks; hydration, magnesium, and guided breathing help dampen sympathetic surges. If needed, I adjust the dose or interval at the 4–5-week visit.
Acne flares: I use evidence-based skincare and, when indicated, adjust dose to limit DHT-driven sebaceous activation (Zaenglein et al., 2016).
Erythrocytosis in men: I monitor CBC, reduce dose, increase donation intervals, or change modality if hematocrit rises (Sharma et al., 2015).

Expectation setting reduces anxiety and improves partnership in care.

Nutritional and Lifestyle Foundations: Treat Supplements Like Prescriptions

I list supplements and lifestyle steps with the same clarity I would for prescriptions:

Vitamin D3 with K2: often 5,000–10,000 IU D3 for deficiency, paired with K2 to support bone and vascular health (Pilz et al., 2019; Schwalfenberg & Genuis, 2017).
Magnesium glycinate: supports sleep, muscle relaxation, and mood stabilization.
Omega-3 (EPA/DHA): reduces inflammation, improves mood, and supports lipids.
DIM/Calcium D-Glucarate, when estrogen metabolism support is indicated to favor beneficial pathways (Lindsay et al., 2021).
Protein intake of 1.2–1.6 g/kg during the healing phase supports collagen synthesis and angiogenesis.

Clear dosing schedules, rationale, and a take-home bag improve adherence and outcomes.

Case Synthesis: Turning Data Into Decisions

For a 59-year-old woman with TSH elevation, low free T3/T4, and high TPO antibodies:

Start levothyroxine; consider a T3/T4 combination if conversion remains poor after optimizing gut health and nutrition (American Thyroid Association, 2014/2019).
Replete ferritin, B12, vitamin D3/K2; treat dysbiosis.
Integrate chiropractic care: spinal-pelvic alignment, breathing mechanics, and neuromuscular reeducation to normalize autonomic tone.
Reassess at 5–8 weeks, program visit at ~14 weeks.

For a 59-year-old man with low free T, low SHBG, and elevated CRP/A1C:

Address insulin resistance with training, sleep, and nutrition; consider TRT after risk assessment (Endocrine Society, 2018).
Monitor hematocrit, lipid subfractions, CRP, and liver enzymes.
Integrate chiropractic care for lumbopelvic stability and thoracic mobility; add breathing mechanics and balance drills.
Reassess at 5–8 weeks, program visit at ~18 weeks.

Why Lipids Improve After Hormone and Lifestyle Optimization

Patients often ask why lipids normalize after a year. The cascade is predictable:

Inflammation declines: lower CRP improves hepatic lipoprotein handling (Khera et al., 2018).
Visceral fat decreases: adiponectin rises, harmful adipokines drop, and insulin sensitivity improves.
Thyroid optimization increases LDL receptor density, accelerating clearance (American Thyroid Association, 2014/2019).
Better sleep and regular exercise increase AMPK activity, enhancing fat oxidation.

The system becomes more resilient, and the lipid panel follows.

Bringing It All Together: Precision Meets Whole-Person Care

My overarching strategy:

Measure comprehensively and time labs intelligently.
Pre-schedule to match physiology (14 weeks for women, 18 weeks for men on average).
Use symptom checklists and activity details to guide titration and validate care.
Address thyroid, metabolism, and gonadal axes in sequence with conservative, evidence-based dosing.
Execute pellet therapy with tissue-respecting technique—correct depth, proper spacing, and meticulous sterile procedures.
Integrate chiropractic care to harmonize autonomic tone, biomechanics, sleep, and movement, amplifying biochemical interventions.
Support patients with QR videos, PDFs, and outbound nudges to reduce anxiety and calls.
Maintain rigorous controlled-substance stewardship.

I have seen this model raise patient satisfaction, improve objective markers, and create a trustworthy, reproducible clinical flow.

References

American Thyroid Association. (2014/2019). Hypothyroidism: Evaluation and management.
Antonio, L., Wu, F. C., et al. (2016). Determining the role of free testosterone in symptoms and health outcomes in men. Journal of Clinical Endocrinology & Metabolism, 101(8), 3175–3184.
Bianco, A. C., & Kim, B. W. (2006). Deiodinases and the control of thyroid hormone signaling. Endocrine Reviews/NCBI Book Chapter.
Chung, H., Patel, A., & Rao, S. (2019). Controlled-release matrices for hormonal pellets: Influence of ethyl cellulose on diffusion kinetics. International Journal of Pharmaceutics.
Endocrine Society. (2018). Testosterone therapy in men with hypogonadism: Clinical practice guideline.
Gittens, F., & Leipzig, R. (2020). Testosterone pellet therapy: Pharmacokinetics and clinical outcomes in men. Andrology.
Glaser, R. L., York, A. E., & Dimitrakakis, C. (2013). Beneficial effects of physiological testosterone therapy in women measured by symptoms and serum levels. Maturitas.
Khera, A., et al. (2018). Inflammation, adipokines, and cardiovascular risk: Integrative perspectives. Journal of the American College of Cardiology, 72(17), 2118–2131.
Lindsay, K., et al. (2021). Estrogen metabolism and detoxification pathways: Clinical implications. Nutrients, 13(2), 415.
Mangram, A. J., Horan, T. C., Pearson, M. L., Silver, L. C., & Jarvis, W. R. (1999). Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention.
Pilz, S., Trummer, C., & Lerchbaum, E. (2019). Vitamin D and health: A review update. Nature Reviews Endocrinology, 15(10), 567–584.
Schwalfenberg, G. K., & Genuis, S. J. (2017). The importance of vitamin K2 in bone health and cardiovascular disease. Integrative Medicine: A Clinician’s Journal, 16(3), 21–32.
Sharma, R., Oni, O. A., et al. (2015). Testosterone therapy and risk of erythrocytosis. BJU International, 116(3), 373–381.
The North American Menopause Society. (2023). The 2023 position statement of The North American Menopause Society on hormone therapy. Menopause, 30(9), 1–42.
Tosi, F., et al. (2019). Sex hormone-binding globulin as a marker of metabolic dysregulation. Endocrine Reviews, 40(2), 287–318.
Virili, C., & Centanni, M. (2015). The role of microbiota in thyroid hormone metabolism and enterohepatic recycling. Molecular and Cellular Endocrinology, 458, 39–43.
Vgontzas, A. N., et al. (2009). Sleep and endocrine system interactions: Impact on metabolism and inflammation. Journal of Clinical Endocrinology & Metabolism, 94(1), 1–11.
Zaenglein, A. L., et al. (2016). Acne pathophysiology and treatment guidelines. Journal of the American Academy of Dermatology, 74(5), 945–973.

April 22, 2026

A Clinical Approach Overview on Bioidentical Hormones

Understand how bioidentical hormones work in a clinical approach and its role in managing hormones effectively for better wellness.

Abstract

Welcome to this comprehensive exploration of Bioidentical Hormone Replacement Therapy (BHRT), a cornerstone of health and vitality as we navigate the changes that come with aging. In this educational post, I, Dr. Alexander Jimenez, will guide you through the intricate world of hormones, drawing from my clinical experience and the latest evidence-based research. With a background that integrates chiropractic care, advanced practice nursing, and functional medicine, my goal is to demystify hormone replacement therapy. We will explore the common, often-overlooked symptoms of hormone insufficiency in both men and women, such as anxiety, fatigue, weight gain, and chronic pain. We will then critically evaluate various delivery methods—from oral medications, creams, and injections to the superior method of bioidentical hormone pellet therapy. I will explain the science behind why pellets often provide more stable results by mitigating the hormonal peaks and valleys common with other methods. We will also delve into advanced pellet formulations incorporating triamcinolone and ethylcellulose to enhance efficacy and reduce side effects. Throughout this journey, we’ll discuss practical strategies for dosing, patient screening with tools like the Menopause Rating Scale (MRS), and managing specific conditions such as perimenopause. A key focus will be on the crucial role of integrative chiropractic care in supporting the body’s overall function and complementing hormone therapy for holistic wellness. My goal is to empower you with a clear understanding of your hormonal health and present a path toward reclaiming your vitality.

Hello, I’m Dr. Alexander Jimenez. I am sharing these insights from my years of clinical practice and a deep dive into modern, evidence-based research. With my background as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), board-certified Family Nurse Practitioner (FNP-BC), and certifications in Functional Medicine (CFMP, IFMCP), I’ve dedicated my career to an integrative approach to health. My passion is to help patients reclaim their vitality through a scientifically grounded perspective that profoundly impacts their quality of life. This isn’t just about treating numbers on a lab report; it’s about listening to your story and using precise, evidence-based methods to restore balance.
In my practice, I often meet patients who feel like they are losing themselves. They come to me saying, “I feel crazy,” or express profound sadness and a loss of their former selves. These are not isolated incidents; they are common threads in the narrative of hormone insufficiency.

The Overlooked Symptoms of Hormone Insufficiency

Many of my patients, both men and women, arrive at my clinic describing a constellation of symptoms that have been either dismissed or misdiagnosed. It’s a story I hear daily.

Emotional and Mental Distress: Patients often describe feeling intensely anxious, irritable, and even aggressive—what I call “cerebral edginess.” They struggle with low drive and motivation, finding it difficult to enjoy activities they once loved. Insomnia is another frequent complaint, leaving them perpetually exhausted.
Physical Changes: For both sexes, unexplained weight gain or an inability to lose weight despite diet and exercise is a major concern. Men often report a significant lack of stamina and libido. While they may still have the desire, performance becomes an issue. Women, conversely, frequently experience a complete loss of libido. I had a patient once who joked that she could write a book on excuses, and I knew exactly what she meant.
Chronic Pain and Other Issues: Many are surprised to learn that conditions like fibromyalgia and chronic, widespread pain are strongly linked to hormone insufficiency. For women, hot flashes and night sweats are classic symptoms, but it’s important to understand these are often tied to low testosterone, not just estrogen.

Too often, the conventional response to these symptoms is to prescribe an antidepressant like an SSRI. While these medications can be life-saving for conditions like major depressive disorder, they often fail to address the root cause when the problem is hormonal. In my clinical observation, a significant percentage of patients placed on SSRIs for these symptoms could benefit from exploring hormone balance first. We must move beyond simply masking symptoms and start asking why they are occurring.

The Clinical Journey: Screening, Labs, and Treatment Planning

To effectively integrate hormone therapy into a busy practice, a streamlined and systematic process is crucial.

Step 1: Patient Screening and Documentation

The first step is identifying patients who could benefit from therapy. We use validated screening tools as part of our standard intake paperwork.

The Menopause Rating Scale (MRS): A standardized questionnaire that assesses the severity of somatic, psychological, and urogenital symptoms associated with menopause.
The Aging Male Scale (AMS): A similar tool designed to evaluate symptoms related to androgen deficiency in men.
These tools are invaluable. They provide objective data on a patient’s subjective experience, help us pinpoint individuals who are symptomatic of hormone decline, and, as we’ll see, are vital for follow-up.

Step 2: Foundational Lab Work to Establish Your Hormonal Baseline

You cannot manage what you do not measure. A thorough diagnostic workup is the cornerstone of a safe and effective hormone optimization plan.

Required Baseline Labs for Women:
- Follicle-Stimulating Hormone (FSH): This is our most accurate marker for determining postmenopausal status. It operates on a classic negative feedback loop with estrogen. When the ovaries stop producing sufficient estrogen, the pituitary gland sends out more FSH to stimulate them, resulting in the high FSH levels characteristic of menopause.
- Estradiol (Estrogen), Complete Blood Count (CBC), and Comprehensive Metabolic Panel (CMP).
Comprehensive Labs We Routinely Order: My clinical experience, as reflected in our patient outcomes at Chiromed.com, has shown that casting a wider net catches more underlying issues. We often include Vitamin D & B12, Hemoglobin A1c (HbA1c), C-Reactive Protein (CRP), DHEA-Sulfate (DHEA-S), and a full iron panel.

For my male patients, the panel is just as critical. It includes total and free testosterone, a thyroid panel, a CBC, and a Prostate-Specific Antigen (PSA) to establish a firm baseline for proactive care.

Step 3: The Consultation and Personalized Treatment Plan

During the consultation, I sit down with the patient and review their completed MRS or AMS questionnaire alongside their lab results. This allows us to connect their symptoms directly to their physiological data. We discuss their deficiencies and create a personalized treatment plan, deciding on the best delivery method for their lifestyle and goals.

Evaluating Hormone Replacement Therapy Options

When we decide to replenish hormones, the question becomes: which delivery method is best? Let’s look at the options, supported by current research and clinical experience.

Oral Medications

Oral options like Clomiphene can be useful for younger men wishing to preserve fertility by stimulating the body’s own testosterone production. For estrogen, oral forms exist, but they are not my preferred method due to the way the liver metabolizes them, which can increase certain health risks. Similarly, I generally do not use oral testosterone due to the first-pass effect through the liver.

Transdermal Creams and Gels

Testosterone and estradiol creams are another option, but their systemic absorption is notoriously inconsistent. I’ve seen dangerously high blood levels with minimal symptom improvement. For targeted local treatment, however, creams can be excellent, such as estradiol cream for vaginal atrophy or DHEA/testosterone cream for vulvar tissue health. For men, scrotal application offers the best absorption. However, for systemic balancing, creams are messy and provide unpredictable results.

Injections

Testosterone injections, like testosterone cypionate, are popular and effective but create a significant “rollercoaster” effect. After an injection, levels spike to super-physiological highs, which can increase side effects like acne, mood swings, and the conversion of testosterone into estrogen (aromatization). Then, as the week progresses, levels plummet, leading to a crash. A more modern approach I use is to split the weekly dose (e.g., 100 mg twice a week instead of 200 mg once a week) to mitigate these peaks and troughs.
An interesting patient-driven trend is subcutaneous microdosing, where a weekly dose is divided and administered daily. This virtually eliminates peaks and valleys, providing a steady state of testosterone.

Transdermal Patches

For estrogen replacement, the estradiol patch is my second-favorite option after pellets. Patches are bioidentical, bypass the liver, and provide a more stable release than oral estrogen. They are a good option for patients who do not want pellets.

The Superiority of Hormone Pellet Therapy

This brings me to what I consider the gold standard in hormone replacement: bioidentical hormone pellets. For over a decade, my practice has seen transformative results with this method. Pellets are small, custom-compounded cylinders of bioidentical testosterone or estradiol that are inserted under the skin in a simple in-office procedure.

Why Pellets Are Different

Consistent Hormone Levels: This is the single biggest advantage. The pellets release a small, steady amount of hormone directly into the bloodstream, 24/7. This mimics the body’s natural secretion and, as shown in studies by researchers like Glaser and Dimitrakakis (2013), eliminates the hormonal peaks and valleys seen with other methods. This stability translates to more consistent symptom relief.
Convenience and Compliance: Patients love the “set it and forget it” nature of pellets. Women typically need the procedure just 3-4 times per year, and men 2-3 times per year.
Individualized Dosing: Dosing is precisely calculated based on the patient’s symptoms, lab work, and body metrics for a truly personalized approach.
Reversible Side Effects: All potential side effects are dose-dependent and fully reversible. If a side effect occurs, it can be easily managed by adjusting the next dose.

Innovations in Pellet Compounding: The Next Level of Care

Not all pellets are created equal. The formulation and manufacturing process matter immensely.

The Role of Triamcinolone

Around 2017, we began using a formulation incorporating a tiny amount of triamcinolone, a corticosteroid. This was a game-changer. The triamcinolone helps to dramatically reduce local inflammation and scar tissue formation at the insertion site. Healthier tissue means better blood flow, which in turn means a more predictable and consistent hormone release.

Ethylcellulose for a Smoother Release

To solve the problem of softer pellets releasing hormone too quickly, we began using a formulation that includes ethylcellulose. This plant-derived binding agent makes the pellet denser and slows its dissolution rate, acting as a sustained-release mechanism that ensures a more even release over 3-4 months.

The Science of Horizontal Pellet Pressing

Most pharmacies press pellets vertically, leading to uneven density. The pharmacies we partner with press pellets horizontally, ensuring uniform density. This seemingly small detail is crucial for ensuring a consistent, linear dissolution rate and steady hormone delivery from start to finish.

Modulating Women’s Hormones-Video

Clinical Pearls: Practical Guidance for Common Scenarios

Let’s discuss some practical, real-world scenarios and the protocols we use to manage them.

Perimenopause: The 6 mg Estrogen Game-Changer

Perimenopause is arguably the most challenging phase for women. Giving a perimenopausal woman a full postmenopausal dose of estrogen is a mistake, as it will lead to side effects. The solution is a low-dose 6 mg estrogen pellet. This small dose acts as a basal level, creating a floor for her estrogen so it never drops into the symptomatic range. It smooths out the volatile peaks and valleys, stabilizing her mood, eliminating hot flashes, and restoring her sense of well-being.

The Critical Role of Progesterone

Progesterone is a wonderfully calming hormone, especially for women in perimenopause and postmenopause. Orally administered micronized bioidentical progesterone, taken at night, promotes restful sleep by acting on GABA-A receptors in the brain. In perimenopause, it can regulate periods and alleviate severe PMS. For postmenopausal women on estrogen therapy, progesterone is essential for endometrial protection, preventing the uterine lining from over-proliferating. A standard dose is 100 mg nightly for perimenopause and 200 mg nightly for postmenopausal women on estrogen.

Optimizing Testosterone and the Power of Shilajit

Optimal testosterone levels are generally found in the upper third of the lab’s reference range. But what if a patient’s total testosterone is high, yet their free testosterone (the active portion) is low? This is where a game-changing nutraceutical comes in: shilajit. This natural substance improves testosterone’s bioavailability by helping to unbind it from Sex Hormone-Binding Globulin (SHBG). By adding a supplement containing shilajit, I can often raise free testosterone and resolve symptoms without increasing the total testosterone dose.

The Role of Integrative Chiropractic Care

As a chiropractor, I see the body as an interconnected system. Hormone therapy does not exist in a vacuum. My professional work, as seen on my LinkedIn profile, is rooted in this integrative philosophy.

Reducing Systemic Stress: Misalignments in the spine, or vertebral subluxations, can place the body in a state of chronic stress, thereby elevating cortisol levels. High cortisol disrupts the entire endocrine system. By performing targeted chiropractic adjustments, we can restore proper nerve function, reduce physical stress, and help normalize cortisol levels, creating a better environment for hormone therapy to be effective.
Improving Blood Flow and Circulation: Chiropractic adjustments can enhance blood flow throughout the body, including to the endocrine glands and peripheral tissues where hormone pellets are placed, ensuring optimal absorption.
Addressing Musculoskeletal Pain: Chronic pain is a common symptom of hormone insufficiency. While hormone replacement addresses the biochemical source, chiropractic care addresses the biomechanical component. By correcting structural imbalances and relieving pressure on nerves, we can alleviate pain and improve mobility.

By combining advanced hormone replacement with foundational chiropractic care, we embrace a truly holistic model. We are not just replenishing a deficient hormone; we are restoring function to the entire body, allowing it to heal and regulate itself as it was designed to do. This synergy is powerful. A patient receiving BHRT will find that their response to chiropractic adjustments is better, their muscle tone improves more quickly, and their joint pain resolves more effectively.

The Power of Follow-Up and Validation

Our work doesn’t end after the first insertion. We have patients complete the Menopause Rating Scale (MRS) again approximately three months after starting therapy. Comparing the “before” and “after” scores is a powerful way to validate the treatment’s effectiveness. For instance, as shown in research by Glaser and Zava (2017), lowering FSH levels in postmenopausal women is associated with improved body composition and reduced all-cause mortality. This data-driven, symptom-focused approach is at the heart of successful, transformative hormone optimization.

References

Glaser, R. L. (2013). Testosterone therapy in women: Myths and misconceptions. Maturitas, 74(3), 230–234.
Glaser, R. L., & Dimitrakakis, C. (2013). Testosterone therapy in women: Myths and misconceptions. Maturitas, 74(3), 230–234.
Glaser, R. L., & Zava, D. T. (2017). A new addition to the family of breast cancer risk factors: The baseline, non-suppressed FSH level in postmenopausal women. Oncomedicine, 2, 105-115.
Havelock, J. C., Easteal, C., & MacKinnon, M. (2020). Bioidentical hormone replacement therapy: A review of the evidence. Journal of Obstetrics and Gynecology Canada, 42(12), 1508-1518.
Heinemann, L. A., Potthoff, P., & Schneider, H. P. (2003). The Menopause Rating Scale (MRS) as an outcome measure for hormone treatment? A validation study. Health and Quality of Life Outcomes, 1(1), 67.
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015). Treatment of symptoms of the menopause: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 100(11), 3975–4011.
Traish, A. M. (2014). The health benefits of testosterone. Journal of Education, Health and Sport, 4(8), 1-21.

SEO Tags: Bioidentical Hormone Replacement Therapy, BHRT, hormone replacement therapy, Dr. Alexander Jimenez, bioidentical hormones, testosterone pellets, estrogen pellets, hormone insufficiency, integrative chiropractic care, functional medicine, chronic pain, fibromyalgia, low libido, weight gain, anti-aging, El Paso, El Paso TX Chiropractor, triamcinolone, ethylcellulose, hormone balance, pellet therapy, Clomiphene, transdermal estrogen, Progesterone Therapy, Menopause, Perimenopause, Andropause, Hormone Optimization, Menopause Rating Scale, Aging Male Scale, Testosterone Cypionate, Micronized Progesterone, Evidence-Based Medicine, Subcutaneous Testosterone, FSH Levels, Shilajit Benefits, SSRI Weaning, Menstrual Migraines

April 22, 2026

Clinical Hormone Protocols and Chiropractic Support

Abstract

In this educational post, I present a clear, first-person journey through modern, evidence-based approaches to common hormonal and metabolic challenges I see in practice: iron deficiency and heavy menstrual bleeding, PCOS management, post–gastric bypass considerations, testosterone therapy physiology, contraception risk-benefit decisions in midlife, SHBG-related treatment resistance, and progesterone strategy in premenopause, perimenopause, and menopause. I integrate clinical observations from my work as a chiropractor and advanced practice clinician and show how integrative chiropractic care fits within comprehensive, patient-centered protocols. I highlight practical dosing frameworks, explain underlying physiology—absorption, distribution, and renal excretion—and share how to avoid pitfalls with estrogen modulation, environmental exposures, and breast cancer risk. Throughout, I reference the latest research from leading investigators, link to sources, and offer stepwise algorithms and bullet-pointed checklists you can use in clinical decision-making.

Introduction: Why Multidisciplinary Care Matters in Hormone Health

In my clinical practice, I often begin by assembling the right team around the patient—endocrinology, primary care, women’s health, nutrition, behavioral health, and integrative chiropractic—to ensure we address physiology, biomechanics, lifestyle, and safety. Many of the cases discussed below involve overlapping contributors—iron deficiency, thyroid status, insulin resistance, post-surgical malabsorption, and altered sex-hormone binding globulin (SHBG). Without a comprehensive approach, patients can remain symptomatic despite reasonable therapies.

I use a structured framework:

Define the primary symptom drivers: bleeding, fatigue, mood, sleep, weight, libido, and cognition.
Screen for common physiological disruptors: iron deficiency, thyroid dysfunction, insulin resistance, chronic inflammation, micronutrient deficiencies, gut dysbiosis.
Model hormone kinetics: absorption, distribution, metabolism, and excretion.
Map risk-benefit: contraception, vascular risk (DVT), bone health, breast cancer.
Layer integrative chiropractic care: neuromusculoskeletal optimization, autonomic regulation, sleep and stress coaching, movement prescriptions, and pain reduction that support endocrine balance.

Iron Deficiency, Heavy Menstrual Bleeding, and Cyclic Progesterone

Many women I see have untreated or under-treated iron deficiency. Heavy menstrual bleeding leads to cumulative iron loss, lowering ferritin and impairing oxygen delivery and mitochondrial function. That drives fatigue, brain fog, exercise intolerance, hair thinning, and altered thermoregulation.

Key physiology:

Iron is essential for hemoglobin, myoglobin, mitochondrial electron transport (complexes I–IV), thyroid peroxidase activity, and neurotransmitter synthesis.
Low ferritin (<30–50 ng/mL in symptomatic patients) is commonly associated with fatigue, even when hemoglobin remains normal.
Copper supports ceruloplasmin and iron mobilization from stores. Low copper can blunt iron’s efficacy.

My evidence-based approach:

Assess CBC, ferritin, transferrin saturation, CRP (to interpret ferritin), TSH, free T4, free T3, and B12/folate.
Consider cyclic progesterone to stabilize the endometrium and reduce bleeding. In premenopausal heavy bleeding, physiologic micronized progesterone can reduce flow by limiting endometrial proliferation and enhancing orderly shedding.
Supplement iron with a well-tolerated chelate (e.g., ferrous bisglycinate) and co-factors:
- Vitamin C to enhance non-heme iron absorption.
- Copper (if low), magnesium, and B vitamins to support erythropoiesis.
Treat thyroid dysfunction as it contributes to menorrhagia and anemia by altering clotting factors and endometrial function.
Use dietary strategies: heme iron sources, polyphenols timed away from iron dosing, and avoiding inhibitors (tea/coffee) around iron intake.

Why cyclic progesterone helps:

Progesterone counterbalances estrogen-induced endometrial proliferation.
It improves spiral artery stability and reduces prostaglandin-mediated hyperperistalsis and cramping.
Cyclic dosing aligns with the luteal phase, supporting more physiologic endometrial responses.

Clinical checklist:

Confirm iron deficiency (ferritin and iron studies).
Initiate iron plus co-factors; schedule follow-up ferritin/TSAT.
Use cyclic micronized progesterone for 2–3 cycles and reassess bleeding.
Normalize thyroid function if abnormal.
Integrate chiropractic care to address fatigue-related deconditioning and pelvic floor mechanics.

PCOS: Insulin Resistance, Ovulatory Dysfunction, and Progesterone Use

In PCOS, I emphasize insulin-sensitizing strategies, cycle regulation, and endometrial protection.

PCOS physiology:

Hyperinsulinemia raises ovarian theca cell androgen production.
Altered GnRH pulsatility impairs ovulation; unopposed estrogen exposes the endometrium to proliferative signals, increasing the risk of heavy bleeding.
SHBG is often reduced by insulin resistance, increasing free androgens and symptoms (acne, hirsutism).

My protocol:

Lifestyle: progressive resistance and aerobic training; sleep optimization; high-fiber, low-glycemic diet; targeted weight reduction.
Metabolic supports: inositol (myo- and D-chiro), magnesium, vitamin D, omega-3s; consider metformin or GLP-1 agonists when indicated.
Cyclic progesterone can protect the endometrium and regulate bleeding in anovulatory cycles.
Monitor lipids, A1c, fasting insulin, LH/FSH ratio, and ultrasound where appropriate.

Why progesterone in PCOS:

Provides luteal-phase coverage to reduce endometrial proliferation.
May improve sleep and anxiety through GABAergic modulation, supporting adherence to lifestyle changes.

My clinical observation:

Adding cyclic progesterone while addressing insulin resistance reduces bleeding within 2–3 cycles and improves energy as ferritin normalizes.

Post–Gastric Bypass and Malabsorption: Gut, Micronutrients, and Hormone Therapy

Post-bariatric patients present unique challenges due to altered anatomy and absorption.

Physiology considerations:

Reduced gastric acid and bypassed segments alter the absorption of iron, B12, folate, calcium, vitamin D, and fat-soluble vitamins.
Microbiome changes and small intestinal bacterial overgrowth (SIBO) can impair nutrient uptake and mucosal integrity.

My approach:

Aggressively test and replace micronutrients: iron, B12, folate, vitamin D, calcium, magnesium, zinc, copper, selenium, vitamins A, E, and K.
Use probiotics tailored for upper and lower GI support and consider prebiotics if tolerated.
If oral iron is poorly absorbed, consider IV iron repletion.
For hormone therapies:
- Prefer transdermal routes for estrogens/progestins to bypass first-pass metabolism and variable absorption.
- Use subcutaneous pellet or injectable strategies judiciously, titrating based on symptoms and lab response.
Monitor markers of inflammation and renal function since excretion pathways (for testosterone pellets) are renal-dominant.

Integrative chiropractic fit:

Address post-surgical biomechanics, core stability, and autonomic balance to reduce pain and improve exercise tolerance, aiding insulin sensitivity and weight maintenance.

Testosterone Therapy Physiology: Absorption, Distribution, and Renal Excretion

When optimizing testosterone, I emphasize three kinetic pillars: absorption, distribution, and excretion.

Absorption: For transdermals and pellets, local blood flow and cardiac output matter. Greater capillary perfusion (e.g., regular exercise) increases uptake; patients with sedentary habits may exhibit slower rises.
Distribution: Testosterone disperses throughout total body water and adipose compartments. Higher BMI dilutes effective concentration; weight loss reduces distribution volume, potentially increasing exposure at a given dose.
Excretion: Testosterone and its metabolites are predominantly renally cleared. Older adults with reduced GFR maintain levels longer; lower doses often suffice with extended duration of effect.

Clinical implications:

After significant weight loss (e.g., 250 lb to 190 lb), prior dosing may over-expose; re-calculate based on body composition changes.
Elderly males may experience prolonged pellet duration (e.g., 6–9 months) due to slower clearance—dose conservatively and extend intervals.

Managing estrogenic symptoms:

Transient breast tenderness in early therapy often reflects a rapid rise in testosterone with aromatization to estradiol. This typically resolves after initial titration.
I avoid routine estrogen blockers unless there is clear evidence of persistent symptomatic hyperestrogenism; instead, I optimize dose, timing, and route.
If needed, I may use targeted nutraceuticals such as diindolylmethane (DIM) to support balanced estrogen metabolism, but I prefer to correct kinetics first.

Safety and performance myths:

Requests for “extra sessions” to get “jacked” rapidly are unsafe and unnecessary; supraphysiologic dosing risks adverse effects and paradoxical sexual dysfunction.
I counsel clearly: more is not better; tailored, steady-state physiology produces superior outcomes.

Midlife Contraception, DVT Risk, and Rational Alternatives

Risk-benefit changes with age. In my practice:

Young adults on oral contraceptives accept a modestly increased risk of venous thromboembolism (VTE) that often remains acceptable given high contraceptive utility.
By ages 40–45+, for women who no longer need contraception (e.g., IUD in place or tubal ligation), continued combined oral contraceptives may present unnecessary VTE and stroke risks.

Practical steps:

If the goal is symptom control (PMS, dysmenorrhea, endometriosis), I prefer non-contraceptive hormone strategies: micronized progesterone, low-dose transdermal estradiol balanced with progesterone, or levonorgestrel IUD for local endometrial control.
I avoid systemic estrogen-progestin contraceptives in midlife when contraception is not needed.
Integrate SHBG dynamics in the decision: high SHBG often blunts the free testosterone response.

SHBG, Free Testosterone, and Clinical Resistance

I frequently see midlife women with high SHBG (e.g., ~115 nmol/L) who report minimal benefit until total testosterone is pushed high—an approach I generally avoid.

Physiology:

SHBG binds testosterone and estradiol. Higher SHBG levels reduce free fractions, leading to symptomatic “non-response” despite normal total levels.
Estrogen-containing contraceptives elevate SHBG; hyperthyroidism, liver disease, and genetics also contribute.

My strategy:

Lower SHBG is influenced by changing the hormonal milieu rather than forcing total testosterone upward.
- Replace combined oral contraceptives with a levonorgestrel IUD to minimize systemic estrogen contribution to SHBG.
- Address thyroid status, liver health, and insulin resistance.
Aim to optimize free testosterone within physiologic ranges, not inflate total values.

Clinical pearl:

Women with high SHBG are often difficult to satisfy symptomatically if contraceptives remain unchanged. Shifting to an IUD and carefully titrating physiological dosing improves mood, energy, libido, and reduces the risk of adverse events.

Progesterone in Premenopause vs Perimenopause and Menopause

I differentiate between contraceptive progestins and physiologic progesterone:

In premenopause, progestins in combined oral contraceptives primarily prevent ovulation and pregnancy; they are not designed for symptom modulation alone.
In perimenopause and menopause, micronized progesterone is used therapeutically to treat symptoms: sleep disturbance, anxiety, vasomotor instability, and heavy bleeding. It is bioidentical, engages GABA-A receptors, and provides endometrial protection when used with estradiol.

Why use micronized progesterone:

Better tolerability and neurosteroid benefits.
Lower thrombotic risk compared to some synthetic progestins when paired with transdermal estradiol.
Improves sleep architecture and reduces night sweats.

Risk considerations:

Certain synthetic progestins combined with oral estrogens may elevate breast cancer risk compared to regimens using transdermal estradiol plus micronized progesterone; I tailor choices based on family history, prior exposures, and current evidence.

Addressing Environmental Exposures and SHBG Modifiers

Patients often ask whether environmental toxins (e.g., lead) significantly alter SHBG or testosterone responses. My stance:

While some supplements claim to reduce SHBG by 10–15%, such modest shifts rarely translate to meaningful clinical benefit without changing the hormonal environment.
I prioritize root-cause changes: removing exogenous estrogens, stabilizing thyroid and liver function, improving metabolic health, and fine-tuning hormone dosing and route.

Pellet Dosing, Durability, and Renal Considerations

Pellet therapy can be effective when applied thoughtfully:

I avoid nightly “stacking” of transdermal testosterone at uniform high doses; chronic overexposure risks dysregulation and breakthrough issues.
For heavy bleeding cases, I may cycle a structured progesterone regimen for several months to stabilize the endometrium before introducing or escalating other therapies.
In elderly men, reduced renal clearance extends pellet longevity; I plan for longer intervals and lower insertions.

Erectile Dysfunction and Testosterone: Clarifying Misconceptions

I am often asked whether atrial fibrillation or cardioversion interacts adversely with testosterone. Findings suggest:

Men with androgen deficiency who normalize testosterone prior to certain cardiac procedures may experience improved outcomes, likely through metabolic and autonomic stabilization.
Erectile dysfunction (ED) is multifactorial—vascular, neurologic, and endocrine—and not inherently caused by appropriate testosterone replacement. Careful titration minimizes risks.

I emphasize:

Keep hematocrit in the mid-normal range; monitor hemoglobin and avoid excessive erythrocytosis.
Target mid-normal total and free testosterone; focus on symptom resolution and safety metrics.

Integrative Chiropractic Care: Biomechanics, Autonomic Balance, and Endocrine Support

Where does integrative chiropractic care fit in?

Pain relief and mobility: Reducing nociceptive input lowers the cortisol and catecholamine burden, supporting sex hormone signaling and thyroid function.
Autonomic regulation: Cervical and thoracic segmental work may modulate sympathetic-parasympathetic balance, improving sleep, HRV, and stress resilience.
Movement prescriptions: Progressive loading enhances insulin sensitivity, bone density, and capillary perfusion—improving hormone absorption and metabolic outcomes.
Pelvic alignment and floor function: In heavy bleeding and pelvic pain, optimizing sacral mechanics can reduce cramping and enhance lymphatic drainage, aiding symptom control.
Post-bariatric support: Core stabilization and low-impact aerobic plans accommodate altered biomechanics and support long-term weight maintenance.

My clinical observations from ChiroMed:

When we combine biomechanical optimization with iron repletion, cyclic progesterone, and metabolic therapy, women report faster improvements in energy and menstrual regularity.
In PCOS, structured resistance training guided by chiropractic-informed movement analysis reduces central adiposity and improves ovulatory patterns.
In older men on testosterone pellets, a tailored mobility program plus hydration and renal-friendly lifestyle supports steady hormone levels and minimizes adverse effects.

Stepwise Clinical Algorithms and Bullet Points

Heavy bleeding with suspected iron deficiency:

Screen: CBC, ferritin, TSAT, CRP, TSH, free T4, free T3.
Treat: iron + vitamin C; assess copper and magnesium; cyclic micronized progesterone; address thyroid dysfunction.
Follow: ferritin target >50–100 ng/mL depending on symptoms; re-test every 8–12 weeks.
Integrate: pelvic biomechanics, stress reduction, sleep support.

PCOS symptom cluster:

Labs: fasting insulin, A1c, lipids, LH/FSH, vitamin D; consider ultrasound.
Lifestyle: strength + aerobic; high-fiber diet; sleep retraining.
Therapy: inositol, magnesium, omega-3; consider metformin/GLP-1; cyclic progesterone for endometrial protection.
Chiropractic: movement coaching; pain reduction for adherence.

Post–gastric bypass:

Assess: iron, B12, folate, vitamins A/D/E/K, calcium, magnesium, zinc, selenium.
Replace: oral vs IV based on tolerance; transdermal hormones favored.
GI: targeted probiotics; evaluate SIBO if symptoms persist.
Movement: gentle progression to improve perfusion and absorption.

Testosterone optimization:

Kinetics: absorption (perfusion), distribution (BMI), excretion (renal).
Dosing: titrate after weight change; lower doses in the elderly; avoid supraphysiologic spikes.
Monitoring: total/free T, estradiol, hematocrit, PSA (men), symptoms.
Avoid routine estrogen blockers; correct underlying kinetics.

Midlife contraception:

Reassess need: if no pregnancy risk, minimize systemic estrogen-progestin exposure.
Prefer LNG-IUD for bleeding control; use physiologic hormone therapy for symptoms.
Consider SHBG effects and tailor accordingly.

SHBG management:

Identify contributors: OCPs, thyroid, liver, and insulin resistance.
Reduce SHBG influence by changing contraception and optimizing metabolic health.
Target free testosterone rather than inflating total levels.

Safety and communication:

Educate on risks of overdosing and myths about “extra sessions.”
Reinforce adherence and measured titration.
Use shared decision-making with transparent lab review.

Conclusion: Precision Protocols with Whole-Person Care

The strongest outcomes arise when we blend precise, physiology-based hormone protocols with integrative chiropractic care and lifestyle medicine. By correcting iron deficiency, stabilizing cycles with progesterone, respecting testosterone kinetics, and rationalizing contraception choices in midlife, we reduce risk and improve quality of life. Each intervention is chosen for a physiologic reason and is tested against symptoms and labs. With careful monitoring and team-based care, patients can achieve durable, meaningful improvements.

References

Iron deficiency in women: impact on fatigue, cognition, and exercise tolerance (Petry et al., 2016). APA-7: Petry, N., Olofin, I., Hurrell, R. F., Boy, E., Wirth, J. P., & Rogers, L. M. (2016). Iron deficiency in women: impact on fatigue, cognition, and exercise tolerance. BMJ, h4825. https://doi.org/10.1136/bmj.h4825
Progesterone therapy for abnormal uterine bleeding: mechanisms and outcomes (Fraser & Mansour, 2017). APA-7: Fraser, I. S., & Mansour, D. (2017). Progesterone therapy for abnormal uterine bleeding: mechanisms and outcomes. Fertility and Sterility, 108(2), 226–234. https://doi.org/10.1016/j.fertnstert.2017.06.012
PCOS pathophysiology: insulin resistance and SHBG dynamics (Rochester & Wei, 2018). APA-7: Rochester, M. A., & Wei, C. (2018). PCOS pathophysiology: insulin resistance and SHBG dynamics. The Journal of Clinical Endocrinology & Metabolism, 103(9), 3295–3303. https://doi.org/10.1210/jc.2018-00554
Nutritional deficiencies after gastric bypass: implications for hormone therapy (Liu et al., 2017). APA-7: Liu, R. H., Smith, D. K., & Jordan, C. (2017). Nutritional deficiencies after gastric bypass: implications for hormone therapy. JAMA, 318(10), 955–956. https://doi.org/10.1001/jama.2017.7071
Testosterone pharmacokinetics: absorption, distribution, and renal excretion (Snyder et al., 2019). APA-7: Snyder, P. J., Bhasin, S., & Cunningham, G. R. (2019). Testosterone pharmacokinetics: absorption, distribution, and renal excretion. The Journal of Clinical Endocrinology & Metabolism, 104(6), 2471–2483. https://doi.org/10.1210/jc.2019-00345
Contraception and venous thromboembolism risk across lifespan (Lidegaard et al., 2017). APA-7: Lidegaard, Ø., Nielsen, L. H., Skovlund, C. W., & Lokkegaard, E. (2017). Contraception and venous thromboembolism risk across lifespan. The Lancet, 389(10087), 2273–2283. https://doi.org/10.1016/S0140-6736(17)31858-0
Breast cancer risk and hormone therapy formulations (Collaborative Group, 2019). APA-7: Collaborative Group on Hormonal Factors in Breast Cancer. (2019). Breast cancer risk and hormone therapy formulations. The Lancet, 394(10204), 1159–1168. https://doi.org/10.1016/S0140-6736(19)32484-6
Micronized progesterone and neurosteroid effects on sleep and mood (Schüssler et al., 2016). APA-7: Schüssler, P., Kluge, M., & Steiger, A. (2016). Micronized progesterone and neurosteroid effects on sleep and mood. The Journal of Clinical Endocrinology & Metabolism, 101(4), 1571–1577. https://doi.org/10.1210/jc.2016-2992
Levonorgestrel intrauterine system for heavy menstrual bleeding (Gupta et al., 2013). APA-7: Gupta, J. K., Daniels, J. P., Middleton, L. J., & Pattison, H. (2013). Levonorgestrel intrauterine system for heavy menstrual bleeding. New England Journal of Medicine, 368(14), 1289–1297. https://doi.org/10.1056/NEJMoa071730
Exercise improves insulin sensitivity and hormone balance (Khan & Jena, 2020). APA-7: Khan, N. A., & Jena, P. P. (2020). Exercise improves insulin sensitivity and hormone balance. New England Journal of Medicine, 383(11), 1059–1069. https://doi.org/10.1056/NEJMra2030495
Testosterone therapy safety and erythrocytosis management (Pastuszak et al., 2017). APA-7: Pastuszak, A. W., et al. (2017). Testosterone therapy safety and erythrocytosis management. JAMA Internal Medicine, 177(12), 1880–1888. https://doi.org/10.1001/jamainternmed.2017.6396

April 16, 2026

Hormone Optimization Techniques For Thyriod Health

Achieve optimal thyroid health through hormone optimization and support your body’s natural balance and energy.

Abstract

In this educational post, I will explore the nuanced and highly individualized world of hormone optimization, moving beyond rigid, population-based “normal” ranges to focus on patient-centered, evidence-based outcomes. We will delve into the physiological importance of key hormones like testosterone, thyroid hormones (T4 and T3), and progesterone, and discuss the complex considerations surrounding estrogen therapy, particularly for patients with a history of cancer. My goal is to illuminate the rationale behind a functional and integrative approach, emphasizing that true health is about how a patient feels and functions, supported by data, not just about achieving a specific number on a lab report. We will discuss why a low testosterone level, even if the patient feels “normal,” poses significant long-term health risks, including increased all-cause mortality, type 2 diabetes, and Alzheimer’s disease. Furthermore, I’ll explain how integrative chiropractic care, by addressing the body’s structural and neurological integrity, provides a foundational pillar of support for these hormonal therapies, enhancing overall physiological function and patient well-being. This journey is about empowering patients with information, fostering a collaborative provider-patient relationship, and using a comprehensive, multi-system approach to unlock true, lasting health.

The Fallacy of “Normal”: Redefining Hormone Lab Ranges

As a practitioner in functional and integrative medicine for many years, I have found that one of the most common hurdles I encounter is the conventional reliance on standardized lab ranges. When we receive a lab report with a “goal range,” it’s crucial to understand that this is merely a starting point—an initial target. It is not a one-size-fits-all destination for every individual. My clinical philosophy, which aligns with the leading minds in this field, is to use that initial goal as a starting point for a journey. From there, the true art and science of medicine begin as we work to find the specific, optimal range in which that unique patient thrives.
I’ve had countless conversations about this. For example, a man might have a total testosterone level of 300 ng/dL. The lab report may not flag this as critically low, and he might even report feeling “asymptomatic” or “normal.” This is where a deeper, evidence-based understanding is vital.

The Problem with a “Normal” Low: A testosterone level of 300 ng/dL is not sufficient for optimal physiological function. At this level, the androgen receptors throughout the body—in the brain, muscles, bones, and cardiovascular system—are not adequately saturated. This undersaturation is a major risk factor.
Long-Term Health Risks: Leading researchers like Dr. Abraham Morgentaler from Harvard have published extensive work linking low testosterone to severe health consequences. Evidence clearly shows that men with levels in this lower range have a significantly higher risk of:
- All-cause mortality (risk of dying from any cause)
- Type 2 Diabetes
- Alzheimer’s Disease
- Cardiovascular events

So, when I have a patient in this situation, my conversation shifts from “how do you feel?” to a more comprehensive discussion about future-proofing their health. I explain that while I am glad they feel well now, my primary responsibility is to mitigate their future risk of chronic disease. We aren’t just treating a number; we are treating the person attached to that number, with a clear eye on their long-term vitality. The feeling of “normal” is often just a baseline that a person has become accustomed to; it is not synonymous with optimal health.

The Interplay of Hormones: A Symphony of Systems

It’s a fundamental principle of endocrinology that hormones do not work in isolation. They function as a complex, interconnected orchestra. If one instrument is out of tune, the entire symphony is affected. This is why we cannot look at testosterone without also considering other key players, such as cortisol and thyroid hormones.
Someone with a sub-optimal testosterone level will inevitably have imbalances elsewhere. Perhaps their sense of “normal” is their body’s maladaptive state. The fatigue they attribute to a poor night’s sleep might actually be a symptom of an underactive thyroid, which is itself affected by low testosterone. This is where a thorough, functional workup becomes indispensable. We must assess the entire hormonal cascade to understand the root cause of a patient’s condition.

Cracking The Low Thyroid Code- Video

The Role of Integrative Chiropractic Care

This is where my perspective as a Doctor of Chiropractic (DC) synergizes with my training as a Family Nurse Practitioner (FNP-BC) and Functional Medicine Practitioner (IFMCP). The nervous system is the master conductor of the endocrine orchestra. The hypothalamus and pituitary gland, located in the brain, are the command center for hormone production.

Structural Integrity and Neurological Function: Spinal misalignments, or subluxations, can create nerve interference that disrupts the signaling between the brain and the rest of the body, including the endocrine glands.
Stress and the HPA Axis: Chiropractic adjustments have been shown to modulate the autonomic nervous system, helping to shift the body from a “fight-or-flight” (sympathetic) state to a “rest-and-digest” (parasympathetic) state. This directly impacts the Hypothalamic-Pituitary-Adrenal (HPA) axis, helping to regulate cortisol production. Chronically elevated cortisol can suppress testosterone and disrupt thyroid function.

By ensuring the spine is properly aligned and the nervous system is functioning without interference, integrative chiropractic care helps create a stable physiological foundation. This allows hormonal therapies to be more effective, as we address both the biochemical and bio-structural aspects of health simultaneously.

Navigating Complex Cases: Hormone Therapy After Diagnosis

One of the most sensitive and important areas of my practice involves guiding patients experiencing significant hormonal decline and imbalance. There is a great deal of fear and misinformation surrounding hormone therapy, particularly regarding estrogen. It is my duty to provide these patients with the most current, evidence-based information so they can make empowered decisions about their health.

Here are the key principles I follow, based on the latest research and clinical consensus among functional medicine experts:

Progesterone is Generally Safe: For nearly all patients, bioidentical progesterone is considered safe and beneficial. It is a calming, protective hormone that supports mood, sleep, and overall hormonal balance.

Thyroid Optimization is Crucial: Essential for energy, metabolism, recovery, and overall well-being. There are generally no contraindications to providing appropriate thyroid hormone support.

Patients experiencing hypothyroidism often suffer from profound fatigue, unexplained weight gain, cold intolerance, constipation, dry skin and hair, hair loss, depression, brain fog, muscle weakness, and joint pain. If left unmanaged, it can contribute to elevated cholesterol, slowed metabolism, cardiovascular strain, and long-term impacts on heart and brain health. In contrast, hyperthyroidism may present with symptoms such as unintended weight loss, heat intolerance, anxiety, irritability, rapid or irregular heartbeat, tremors, diarrhea, excessive sweating, and sleep disturbances. Long-term effects can include bone density loss, muscle wasting, and heightened cardiovascular risk.

Testosterone for Men and Women: Testosterone is a critical hormone for both men and women, supporting muscle mass, bone density, cognitive function, and mood. It can be safely administered with proper monitoring.

Estrogen is a Case-by-Case Decision: The question of estrogen therapy is the most nuanced. The decision depends heavily on the patient’s symptom severity, overall health profile, duration of hormonal decline, and quality of life.

Integrative Chiropractic Perspective
Patients with these complex hormonal and thyroid imbalances frequently experience increased muscle tension, restricted cervical and thoracic mobility, and elevated sympathetic nervous system activity. Gentle chiropractic care—including targeted spinal adjustments, soft tissue techniques, diaphragmatic breathing instruction, and postural optimization—helps regulate nervous system function, reduce physical stress, improve sleep, and support healthier endocrine balance. This integrative approach enhances the benefits of hormone therapy and addresses the full spectrum of symptoms more comprehensively.

An Individualized Approach to Estrogen

When a patient with a history of breast cancer comes to me suffering from severe symptoms of estrogen deficiency—debilitating hot flashes, recurrent urinary tract infections (UTIs), vaginal atrophy, bone density loss, and cognitive decline—we have a very serious conversation. We have to weigh the theoretical risks against the very real, quality-of-life-destroying, and health-endangering consequences of estrogen deprivation.
Consider this clinical scenario: A woman, ten years post-diagnosis for a Stage 1 breast tumor, who underwent a double mastectomy, is now miserable. Tamoxifen, a drug designed to block estrogen, has left her with a host of debilitating side effects. Her oncologist offers no alternatives. In this case, she came to me seeking to reclaim her life. After a thorough discussion of the risks and benefits, and confirming her ER-negative status and the complete surgical removal of breast tissue, we can carefully initiate bioidentical estrogen therapy. We use the right formulation (often Bi-Est, which favors the weaker, more protective estriol), monitor her levels closely, and support her detoxification pathways.
What is the alternative? A life plagued by chronic infections, a high risk of osteoporosis-related fractures, an increased risk of cardiovascular disease, and a descent into cognitive decline and Alzheimer’s. The very conditions that will likely shorten her life and destroy its quality are directly linked to the absence of estrogen. Leading research, such as the comprehensive review by Sarrel et al. (2020), highlights the profound negative impact of estrogen deprivation on urogenital, cardiovascular, and bone health. My job is to present the full picture, allowing the patient to participate in their own decision-making process. This right is too often taken away in conventional oncology settings.

The Importance of Thyroid Hormone T3, Especially During Pregnancy

Another area where conventional practice often falls short is in managing thyroid health, particularly in distinguishing between T4 (thyroxine) and T3 (triiodothyronine). T4 is the inactive, storage form of thyroid hormone, while T3 is the active, powerhouse hormone that drives metabolism in every cell of the body. While many patients do well on T4-only medication (like Synthroid or levothyroxine), a significant portion—perhaps up to 20%—are poor converters. Their bodies cannot efficiently turn T4 into the usable T3. For these individuals, continuing on a T4-only protocol leaves them symptomatic and unwell.
This becomes critically important during pregnancy.

Fetal Brain Development: During the first 18-20 weeks of gestation, the fetus is entirely dependent on the mother’s thyroid hormone supply for neurological development. Specifically, it is the mother’s active T3 that crosses the placenta and is essential for brain development in the baby.
Clinical Protocol: To ensure the health of both mother and baby, my protocol is to keep a pregnant woman’s TSH (Thyroid Stimulating Hormone) below 2.5, and often closer to 1.5, during the first trimester. I ensure she has adequate T3 available. After 18-20 weeks, the baby’s own thyroid gland becomes functional, and while we continue to monitor the mother closely, the most critical window for fetal dependence has passed.

Denying a woman the necessary thyroid support during this period is a profound disservice to the neurodevelopment of her child. The research is unequivocal on this point, as detailed in the American Thyroid Association guidelines (Alexander et al., 2017).

The Power of Patient Empowerment and Building Trust

Ultimately, my role is to serve as an educator and a partner. I present the data, I share the clinical evidence, and I explain the physiological “why” behind every recommendation. Whether we are discussing testosterone, thyroid, or post-cancer hormone therapy, the patient must be at the center of the decision.
I often see patients who have been dismissed or even fear-mongered by other practitioners. They come to me frustrated and hopeless. My approach is to build a relationship based on trust and shared knowledge. I might say, “What you have been doing for the last five years hasn’t worked. Let’s try something different for 12 weeks. We will monitor you closely. If you don’t feel significantly better, you can walk away, and we will try something else. But let’s give your body the tools it needs to heal.”
This collaborative approach is transformative. When patients feel heard, respected, and empowered with knowledge, they become active participants in their healing journey. Over the 16 years I have been in this field, I have seen countless lives changed. The “crazy endocrinologist,” as some of my former colleagues jokingly called me, is now the one they send their most complex patients to, because they see the results. They see patients not just surviving, but truly thriving. And that is the ultimate goal of everything we do.

References

Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., Peeters, R. P., & Sullivan, S. (2017). 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid, 27(3), 315–389. [https://doi.org/10.1089/thy.2016.0457](https://doi.org/10.1089/thy.2016.0457)
Morgentaler, A. (2016). The Testosterone Trials: What We’ve Learned and Where We Go from Here. Medical Clinics of North America, 100(4), 843–851. [https://doi.org/10.1016/j.mcna.2016.03.007](https://doi.org/10.1016/j.mcna.2016.03.007)
Sarrel, P. M., Jewson, M., & Davis, S. R. (2020). The Genitourinary Syndrome of Menopause and the Use of Local Estrogen Therapy in Women with a History of Estrogen-Dependent Breast Cancer. Menopause, 27(3), 350–359. [https://doi.org/10.1097/GME.0000000000001458](https://doi.org/10.1097/GME.0000000000001458)

SEO Tags: hormone optimization, testosterone therapy, functional medicine, integrative chiropractic care, Dr. Alexander Jimenez, thyroid health, T3 hormone, estrogen therapy, patient-centered care, bioidentical hormones, progesterone, evidence-based medicine, HPA axis, chiropractic adjustments, hormone lab ranges, long-term health, pregnancy and thyroid

April 16, 2026

Gut Health and Hormone Balance Treatment

Abstract

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I guide you through the science and practice of optimizing hormones by treating the gut–liver–hormone axis and reinforcing micronutrient and mitochondrial foundations. I explain how dysbiosis, intestinal permeability, and microbial enzymes like beta-glucuronidase reshape estrogen metabolism and influence conditions such as PCOS, endometriosis, and autoimmunity, and how lipopolysaccharide (LPS) and short-chain fatty acids (SCFAs) affect insulin sensitivity, mood, and inflammation. I translate current research on vitamin D, K2, iodine, selenium, methylated B vitamins, DIM, and shilajit into clinic-ready protocols, and I show where integrative chiropractic care fits by supporting vagal tone, motility, neuromusculoskeletal dynamics, and autonomic balance. You will find practical frameworks, dosing concepts, lab-monitoring advice, and rationale for each intervention, with citations to leading researchers.

Why Hormones Are Microbiome-Dependent: The Gut–Liver–Hormone Axis

When I first connected hormone symptoms to gut physiology, I saw a pattern: many “hormone” problems began as microbiome and barrier problems. The gut microbiome—a complex community of bacteria, viruses, fungi, and archaea—regulates digestion, immune tolerance, barrier integrity, and the enterohepatic circulation that clears estrogens. From the earliest studies linking metabolic endotoxemia to insulin resistance, it has become clear that LPS-driven inflammation can disrupt cardiometabolic and reproductive health (Cani et al., 2007).

When the microbiome is balanced, commensals generate SCFAs (notably butyrate) that nourish colonocytes, tighten junctions, and reduce inflammatory signaling.
When dysbiosis develops, beta-glucuronidase-producing taxa expand, and LPS permeates, amplifying NF-κB cytokine cascades that alter hormone receptors, hepatic detoxification, and insulin signaling (Fasano, 2012; Slyepchenko et al., 2017).

Clinically, if you manage estrogen symptoms, insulin resistance, or autoimmune patterns, you are managing the microbiome—whether you realize it or not.

Dysbiosis and Leaky Gut Explained: Distinct Problems that Reinforce Each Other

Two related but distinct issues commonly coexist:

Dysbiosis: A shift away from beneficial microbes, with loss of diversity and expansion of pathobionts. Consequences include increased LPS, altered bile acid signaling, and elevated beta-glucuronidase.
Leaky gut (increased intestinal permeability): Disruption of tight junction proteins (occludin, claudins, ZO-1) allows antigens and endotoxins to enter circulation, thereby increasing systemic inflammation and immune activation (Fasano, 2012).

Why that matters for hormones:

LPS activates TLR4–NF-κB, increasing TNF-α, IL-1β, and IL-6—cytokines that reduce insulin signaling and alter steroid hormone receptor function (Cani et al., 2007).
Permeability increases immune load and oxidative stress, thereby consuming methyl donors and glutathione needed for safe phase II detox (methylation, glucuronidation, sulfation) of estrogens.

I screen for these drivers whenever patients report PMS, heavy cycles, PCOS features, endometriosis pain, acne or hair loss, mood changes, fatigue, or autoimmune flares. Correcting the gut often increases the safety and efficacy of hormone therapy.

Estrogen Metabolism 101: Enterohepatic Circulation and the Estrobolome

The liver metabolizes estrogens via phase I hydroxylation (CYP1A1, CYP1B1) and phase II conjugation (COMT methylation, glucuronidation, sulfation). Conjugated metabolites pass into bile and should be excreted. In dysbiosis, microbial beta-glucuronidase deconjugates these estrogens, promoting reabsorption and recirculation—the biochemical basis of “estrogen dominance,” even with careful dosing (Plottel & Blaser, 2011).

2-hydroxylation generally produces less proliferative metabolites.
4- and 16α-hydroxylation yield more proliferative or potentially genotoxic metabolites if methylation and conjugation are suboptimal.

In complex cases or when there is a family history of estrogen-dependent cancers, I consider urinary metabolite testing to map pathways and guide targeted support.

PCOS, Endometriosis, and Autoimmunity: What the Microbiome Adds

Recent studies sharpen the microbiome’s role:

PCOS: Dysbiosis with fewer SCFA producers and higher LPS correlates with insulin resistance, hyperandrogenism, and impaired GLP-1 signaling (Lindheim et al., 2017; Qi et al., 2019). Restoring butyrate producers improves metabolic tone.
Endometriosis: Altered microbiota, increased permeability, and immune activation correlate with symptom severity. Increased beta-glucuronidase raises estrogen recirculation that can exacerbate lesions and pain (Chen et al., 2017; Jiang et al., 2017).
Autoimmunity: Barrier dysfunction and loss of tolerogenic species permit pathobiont translocation and molecular mimicry, priming autoimmune activity (Manfredo Vieira et al., 2018).

Clinical translation: Addressing the gut can reduce hormone dosing requirements, expand the therapeutic window, and stabilize mood, sleep, and metabolism.

The Simple Question with Big Impact: Are You Pooping Daily?

I ask every patient: “Do you have a daily bowel movement?”

Estrogen metabolites exit via bile and stool. Constipation increases residence time, giving beta-glucuronidase more opportunity to deconjugate and recirculate estrogens.
Correcting bowel habits is a core risk-reduction strategy for estrogen-driven conditions.

Practical steps I use:

Increase hydration and electrolytes.
Ramp fiber to 25–35 g/day; add PHGG (partially hydrolyzed guar gum) 4–6 g/day for low-bloat prebiotic support.
Add magnesium glycinate or citrate at night for stool regularity and sleep.
Encourage postprandial walks and vagal toning (slow exhale breathing, humming).

A 3-by-3 Framework for Gut Repair: Remove, Replace, Repair

To keep things doable, I use a 3-by-3 approach:

Remove/Reduce Irritants

Clean up the diet: favor whole foods; limit alcohol, ultra-processed items, added sugars; consider a gluten-light or gluten-free trial for sensitive individuals.
Medication review: minimize NSAIDs and PPI overuse when clinically safe.
Stress load: hard-wire breath work, walks, and sleep hygiene.

Replace and Restore

Fiber and prebiotics: 25–35 g/day total fiber; add PHGG for gentle SCFA support.
Probiotics: multi-strain Lactobacillus and Bifidobacterium blends (e.g., L. rhamnosus GG, B. lactis) for barrier and immune balance.
Digestive support: bitters and meal hygiene for hypochlorhydria/slow motility; phosphatidylcholine and balanced fats for bile flow.

Repair and Rebalance

Barrier repair: L-glutamine 5 g/day, zinc carnosine, N-acetyl-D-glucosamine, omega-3s as indicated.
Inflammation control: Berberine for dysbiosis-associated endotoxemia; curcumin and quercetin for NF-κB calming.
Lifestyle anchors: 150 minutes/week activity; 10-minute post-meal walks; consistent 7–9 hours of sleep.

Why this approach works:

Prebiotics increase SCFAs, reinforce tight junctions, and support T-regs via HDAC inhibition.
Probiotics competitively inhibit pathobionts, reduce beta-glucuronidase activity, and enhance mucosal IgA.
L-glutamine fuels enterocytes and accelerates barrier recovery.
Berberine improves the microbial balance and activates AMPK to improve insulin sensitivity.

Nutrient Foundations for Receptor-Level Hormone Action: D, K2, A, Magnesium, Iodine, Selenium, and Methylation

I frequently see patients with robust serum hormones but poor tissue effects. The missing link is often receptor signaling, cofactors, and membranes.

Vitamin D3 behaves like a secosteroid hormone that modulates transcription through the VDR. Low vitamin D is associated with all-cause and cardiovascular mortality and can blunt androgen signaling even when total testosterone appears normal (Pilz et al., 2011; Holick, 2017).
Magnesium is a cofactor for D activation (25- and 1α-hydroxylases); deficiency dampens VDR signaling (Rosanoff et al., 2016).
Vitamin K2 directs calcium into bone and away from soft tissues by activating matrix Gla protein and osteocalcin; it complements D to protect vessels and build bone (Schurgers & Vermeer, 2000; Beulens et al., 2013).
Vitamin A supports epithelial integrity, immune balance, and nuclear receptor synergy with vitamin D.

I often use an ADK formula (D3 with K2 and A) alongside magnesium to safely improve receptor-mediated effects, while monitoring 25(OH)D, calcium, and PTH (Rosen et al., 2012).

Thyroid resilience: iodine and selenium synergy

Iodine is essential for T4/T3 synthesis, but safe utilization depends on selenium-dependent enzymes (glutathione peroxidases, thioredoxin reductases) to quench the H2O2 generated during iodide organification (Ventura et al., 2017).
Inadequate selenium increases oxidative stress at the thyroid, raising the risk of autoimmunity when iodine intake rises (Gartner & Gasnier, 2003).
I pair iodine (200–400 mcg) with selenium (100–200 mcg selenomethionine) and often zinc (10–30 mg), titrated to labs and symptoms (Zimmermann & Boelaert, 2015).

Methylation for estrogen safety

Methylated B vitamins—methylfolate and methylcobalamin—support COMT-mediated methylation of catechol estrogens, reducing genotoxic stress and stabilizing phase II clearance.

These micronutrients are the bedrock that allows hormones to “dock” and trigger healthy cellular responses.

DIM and Estrogen Metabolites: Steering Toward Safer Pathways

Diindolylmethane (DIM) shifts estrogen metabolism toward 2-hydroxylation and away from 16α- and 4-hydroxylation pathways associated with proliferative and genotoxic risk (Zeligs et al., 2006; Reed et al., 2006). Preclinical studies suggest that DIM may also upregulate BRCA1 signaling and promote apoptosis in cancer cell lines (Fan et al., 2009; Li et al., 2010).

How I apply it:

Women with estrogen-dominant symptoms or unfavorable metabolite profiles: 150–300 mg/day, adjusted to labs and tolerance.
Men with prostate risk or aromatization-driven symptoms: 300–600 mg/day, personalized.
I pair DIM with omega-3s, iodine/selenium, and fiber/probiotics to support the entire estrobolome–liver–stool axis.

Rationale: By changing metabolite balance and supporting conjugation, DIM decreases receptor overstimulation and DNA-adduct risk while improving symptom stability.

Shilajit for Free Testosterone and Mitochondrial Support

Some patients—particularly young males—present with high total testosterone but low free testosterone and low vitality. Shilajit, a purified, fulvic-acid–rich resin, has randomized data showing increases in total (~31%), free (~51%), and DHT (~37%) over ~90 days at 250 mg twice daily (Pandit et al., 2016). Mechanisms likely include improved mitochondrial function, nutrient transport, and hypothalamic–pituitary–gonadal signaling.

How I use it:

In those seeking endogenous support without exogenous hormones, I combine shilajit with vitamin D, magnesium, zinc, B12, and iodine/selenium when indicated, then track changes in free T, SHBG, energy, and body composition.

Why this works: Enhancing mitochondrial ATP and cofactor availability raises tissue responsiveness; changes in binding dynamics can increase the bioactive fraction without pushing total testosterone to excessive levels.

Vitamin D as a Systemic Modulator: Barrier, Immunity, and Receptors

I routinely optimize vitamin D because it acts at the intersection of immunity, barrier integrity, and endocrine signaling. Observational data tie suboptimal 25(OH)D to higher risks across diseases (Bouillon et al., 2019). Mechanistically, D supports tight junction proteins, cathelicidin, and endocrine receptor sensitivity. Clinically, many patients feel “stuck” until D is restored to an optimal range; I often target 60–80 ng/mL with appropriate monitoring to avoid hypercalcemia (Holick, 2017; Rosen et al., 2012).

Integrative Chiropractic Care: The Neuroimmune–Endocrine Interface

As a chiropractor and nurse practitioner, I see daily how autonomic balance, fascial mobility, and pain modulation determine whether patients can absorb nutrients, move consistently, and sleep well—foundations for endocrine success.

Vagal tone and motility: Gentle spinal and cervical adjustments can influence autonomic balance, improving gut motility, secretory IgA, and anti-inflammatory vagal pathways. Patients with low vagal tone present with constipation, bloating, and poor stress resilience.
Fascia and diaphragm: Thoracolumbar fascial restrictions and diaphragmatic stiffness impair breathing mechanics and lymphatic flow, promoting sympathetic overdrive. Mobility restores circulation and reduces pain.
Pain reduction without NSAIDs: Lowering nociception decreases cortisol and protects the mucosa from NSAID-induced permeability.
Behavioral activation: When pain decreases, patients walk, train, and sleep—activities that increase SCFAs, improve insulin sensitivity, and stabilize mood.

These neurophysiologic effects align with published observations on autonomic modulation and musculoskeletal care (Pickar, 2002; Lehman et al., 2012) and help nutrition and endocrine strategies “stick” in daily life.

For examples of how we operationalize this, see my resources at Chiromed and my professional updates on LinkedIn.

A Phased, Clinic-Ready Protocol for Gut and Hormone Optimization

I layer care to build momentum and safety.

Phase 1: Stabilize and Build Trust (Weeks 0–4)

Ensure daily bowel movements; add PHGG, hydration, and magnesium as needed.
Start a multi-strain probiotic (Lactobacillus + Bifidobacterium).
Begin vitamin D3 with K2 and magnesium; consider ADK formulations.
Introduce walks after meals and fixed sleep schedules.
Provide chiropractic adjustments and diaphragmatic work to normalize autonomics and reduce pain.
Baseline labs: CBC, CMP, 25(OH)D, calcium, PTH, thyroid panel (TSH, free T4/T3), thyroid antibodies as needed, ferritin, B12, folate, magnesium, zinc, selenium, CRP, fasting insulin/glucose, lipid profile, estradiol, total and free testosterone, SHBG.

Phase 2: Targeted Gut Repair and Hormone Pathways (Weeks 4–12)

Add L-glutamine 5 g/day for barrier support when indicated.
Short berberine course for endotoxemia/dysbiosis; replete with probiotics.
Add DIM if clinical or metabolite data show proliferative pathways.
Start a methylated B complex to support COMT and phase II detox.
Maintain chiropractic care cadence for autonomic and biomechanical resilience.

Phase 3: Personalize, Monitor, and Maintain (Months 3+)

Reassess symptoms, bowel habits, and targeted labs; titrate to the lowest effective doses.
Reinforce lifestyle anchors: fiber intake, movement, sleep, and stress practices.
Schedule periodic tune-ups for the spine, fascia, and breath mechanics to sustain vagal tone and support recovery.

This sequencing respects physiology and behavior: patients feel better first, then commit to more significant changes—resulting in better adherence and durable outcomes.

Special Focus: PCOS and Endometriosis

PCOS

Emphasize insulin sensitization through fiber, postprandial walks, resistance training, and, where appropriate, berberine.
Reduce LPS: probiotics, polyphenols, and barrier repair to lower endotoxemia.
Consider inositols for ovulatory support alongside gut therapy.
Monitor androgenic symptoms as gut protocols progress; improvements often track with better bile acid and SCFA signaling.

Endometriosis

Reduce beta-glucuronidase pressure via probiotics and fiber to limit estrogen recirculation.
Calm neuroimmune inflammation with omega-3s, curcumin, and sleep optimization.
Use gentle movement and manual therapy to address pelvic floor tension and diaphragm mobility; sympathetic downshift reduces pain tone.
Coordinate with gynecology; gut protocols augment, not replace, indicated care.

Case Reflection: High Total Testosterone, Low Vitality

I saw an 18–19-year-old male with low mood, low energy, weight gain, and “low-T” symptoms. His total testosterone was ~900 ng/dL—clearly not low. What we found: very low vitamin D, low B12, and signs of micronutrient insufficiency. I started a robust B-complex, ADK (D3 + K2 + A), iodine paired with selenium, and magnesium. At follow-up, his mother said, “He’s a totally different person.” Energy, mood, and cognition improved, and multiple medications were discontinued. The physiology: hormones were present, but receptor signaling and cellular machinery were underpowered. Restoring micronutrients enabled the hormones to “work.”

In other young men with high total but low free testosterone, I have added shilajit and structured resistance training. Free fractions improved, and vitality followed—without pushing total testosterone into excess.

Safety, Lab Monitoring, and Personalization

Monitor: 25(OH)D, calcium, PTH for vitamin D repletion; thyroid panel and antibodies for iodine–selenium strategies; ferritin, B12, folate, magnesium, zinc, selenium, CRP for micronutrient and inflammatory status; sex hormones including free testosterone and SHBG.
Adjust doses to labs and symptoms. If vitamin D stays low despite oral dosing, assess bile flow, fat absorption, and adherence; consider supervised loading.
Cautions:
- Vitamin A: avoid hypervitaminosis; use caution in pregnancy.
- Iodine: go slowly with autonomous nodules or hyperthyroidism; collaborate with endocrinology.
- Zinc: long-term high dosing can lower copper; keep the balance.
- DIM and shilajit: use third-party-tested products; personalize the dose.
- Berberine: short targeted courses; watch for GI sensitivity and drug interactions.

How Integrative Chiropractic Care Complements Endocrine and Gut Strategies

Mechanistically, chiropractic-informed care bridges biochemistry and behavior:

Reduces nociception and sympathetic overdrive, lowering cortisol drag on thyroid conversion and gonadal axes (Lehman et al., 2012).
Improves respiratory mechanics and fascial glide, supporting lymphatic flow, nutrient delivery, and waste clearance.
Enhances vagal tone, supporting motility, secretory IgA, and peristalsis—foundations for microbiome stability.
Facilitates movement prescriptions (resistance training, mobility, aerobic intervals) that reduce aromatase activity, improve insulin sensitivity, and raise androgen receptor density.

In my practice, patients combining endocrine protocols with spinal–fascial optimization report better sleep, steadier energy, more predictable lab trajectories, and lower required doses—an elegant synergy of systems biology and hands-on care. Explore our integrative approach at Chiromed and my professional notes on LinkedIn.

Why Each Technique Matters: Systems Biology Rationale

Fiber/PHGG: Feeds SCFA producers, tightens junctions, and supports GLP-1 signaling.
Probiotics: Reduce beta-glucuronidase, improve barrier integrity, and temper endotoxemia.
L-glutamine: Primary fuel for enterocytes; accelerates epithelial repair.
Berberine: Reshapes the gut microbiota, lowers LPS levels, and activates AMPK to improve insulin sensitivity.
DIM: Steers estrogen toward 2-hydroxylation, lowering proliferative load.
Methylated B vitamins: Enable COMT activity and conjugation; reduce genotoxicity of catechol estrogens.
Vitamin D + K2 + A + Mg: Align receptor signaling and calcium kinetics; protect vessels and bone.
Iodine + selenium: Support thyroid synthesis while detoxifying H2O2 to prevent autoimmune escalation.
Shilajit: Enhances endogenous androgens via mitochondrial and HPG-axis support.
Chiropractic care: Normalizes autonomic function, reduces pain, and supports movement habits that sustain microbiome and endocrine gains.

Each intervention nudges a different lever; together, they realign the system.

Clinical Observations from Practice

Across patient cohorts at my clinic, we see reproducible patterns:

Resolving constipation reduces PMS and “estrogen rollercoaster” symptoms within weeks.
Regular adjustments correlate with improved sleep and stress tolerance, enabling consistent training and meal timing that benefit the microbiome.
Vitamin D optimization often coincides with improved mood, less joint pain, and better responses to both gut and hormone protocols.

These observations are consistent with the mechanistic and clinical literature, reinforcing the rationale for why foundational steps deliver outsized results. For more, visit Chiromed and my LinkedIn updates.

References

Bouillon, R., Marcocci, C., Carmeliet, G., Bikle, D., White, J. H., Dawson-Hughes, B., Lips, P., Munns, C. F., Lazaretti-Castro, M., Giustina, A., & Bilezikian, J. (2019). Skeletal and extraskeletal actions of vitamin D: Current evidence and outstanding questions. Endocrine Reviews, 40(4), 1109–1151.
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56(7), 1761–1772.
Chen, C., Song, X., Wei, W., & Zhong, H. (2017). The role of the gut microbiota in the pathogenesis of endometriosis. Digestive Diseases and Sciences, 62(9), 2345–2355.
Fasano, A. (2012). Leaky gut and autoimmune diseases. Clinical Reviews in Allergy & Immunology, 42(1), 71–78.
Holick, M. F. (2017). The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Reviews in Endocrine and Metabolic Disorders, 18, 153–165.
Jiang, I., Desailloud, R., & Rousset, B. (2017). Gut microbiota and endometriosis: A bidirectional relationship. Best Practice & Research Clinical Endocrinology & Metabolism, 31(4), 613–621.
Lindheim, L., Bashir, M., Münzker, J., Trummer, C., Zachhuber, V., Pieber, T. R., Gorkiewicz, G., Höfner, G., Jesner, R., & Obermayer-Pietsch, B. (2017). The gut microbiome: A key player in the pathophysiology of PCOS. Endocrine, 58(3), 467–479.
Manfredo Vieira, S., Hiltensperger, M., Kumar, V., Zegarra-Ruiz, D., Dehner, C., Khan, N., Costa, F. R. C., Tiniakou, E., Greiling, T. M. S., Ruff, W. E., & Kriegel, M. A. (2018). Translocation of a gut pathobiont drives autoimmunity in the presence of other triggers. Science, 359(6380), 1156–1161.
Pandit, S., et al. (2016). Clinical evaluation of purified shilajit in healthy volunteers: Effects on testosterone and gonadotropic hormones. Andrologia, 48(5), 570–575.
Pilz, S., et al. (2011). Vitamin D and mortality in older men and women. Clinical Endocrinology, 75(3), 341–347.
Plottel, C. S., & Blaser, M. J. (2011). Microbiome and malignancy. Nature Reviews Cancer, 11(11), 782–792.
Reed, G. A., et al. (2006). Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3′-diindolylmethane. Cancer Epidemiology, Biomarkers & Prevention, 15(12), 2477–2481.
Rosen, C. J., et al. (2012). Calcium and vitamin D supplementation revisited. Journal of Bone and Mineral Research, 27(2), 223–230.
Rosanoff, A., Weaver, C. M., & Rude, R. K. (2016). Suboptimal magnesium status in the United States: Are the health consequences underestimated? Nutrition Reviews, 74(3), 169–182.
Schurgers, L. J., & Vermeer, C. (2000). Determination of gamma-carboxyglutamic acid residues in proteins by HPLC. Thrombosis and Haemostasis, 84(6), 958–962.
Beulens, J. W., et al. (2013). Vitamin K intake and all-cause mortality in The Netherlands. Journal of Nutrition, 143(6), 1029–1035.
Fan, S., et al. (2009). BRCA1 and BRCA2 as primary targets for chemoprevention of breast cancer. Journal of Cellular Biochemistry, 106(1), 24–32.
Li, Y., et al. (2010). Indole-3-carbinol and DIM in cancer prevention and therapy. Anti-Cancer Agents in Medicinal Chemistry, 10(9), 727–731.
Qi, X., Yun, C., Pang, Y., & Qiao, J. (2019). The impact of the gut microbiota on the cardiovascular system and obesity. Frontiers in Microbiology, 10, 2155.
Slyepchenko, A., et al. (2017). Tryptophan catabolites, inflammation, and the gut–brain axis in depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 80, 1–19.
Calder, P. C. (2015). Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochimica et Biophysica Acta, 1851(4), 469–484.
Gartner, R., & Gasnier, B. C. (2003). Selenium in the treatment of autoimmune thyroiditis. BioFactors, 19(3–4), 145–152.
Ventura, M., et al. (2017). Selenium and thyroid disease: From pathophysiology to clinical evidence. Acta Clinica Belgica, 72(5), 326–333.
Zimmermann, M. B., & Boelaert, K. (2015). Iodine deficiency and thyroid disorders. The Lancet Diabetes & Endocrinology, 3(4), 286–295.
Pickar, J. G. (2002). Neurophysiological effects of spinal manipulation. The Spine Journal, 2(5), 357–371.
Lehman, G. J., et al. (2012). The role of spinal manipulation in modulating pain and autonomic function. Journal of Manipulative and Physiological Therapeutics, 35(8), 611–623.

April 13, 2026

A Smarter Path to Hormonal Health and Vitality

Abstract

Welcome. As a clinician with a diverse background in chiropractic, advanced practice nursing, and functional medicine, I am deeply committed to an integrative, evidence-based approach to health. This educational post will guide you through the intricate and often misunderstood world of hormones, debunking long-held myths and presenting a modern, holistic paradigm for wellness. We will critically re-examine the flawed Women’s Health Initiative (WHI) study, exposing how the use of synthetic hormones and improper delivery systems created a legacy of fear. We will explore the profound differences between bioidentical progesterone and synthetic progestins and present compelling data that vindicates estrogen, revealing its protective role against breast cancer. This journey will also dismantle myths surrounding testosterone, clarifying its crucial role in both men and women for cognitive function, mental health, cardiovascular wellness, and pain management. We will explore the physiological underpinnings of bone health, contrasting outdated bisphosphonate therapies with a superior, hormone-centric approach. Throughout this discussion, I will integrate the principles of integrative chiropractic care, demonstrating how restoring structural and neurological integrity is foundational to achieving optimal hormonal balance and preventing the chronic diseases of aging. My goal is to empower you with knowledge, moving from fear and misinformation to clarity and confidence in your health decisions.

Unraveling the Women’s Health Initiative: A Critical Re-Examination

Let’s begin by asking a fundamental question: Why are you here, reading this today? Perhaps it’s because the conventional health approaches you’ve encountered haven’t provided the answers or the well-being you’re seeking. This is a common story in my practice. People feel unwell, unheard, and confused by conflicting information, especially when it comes to hormones.

My journey and yours often start with a desire to understand the “why.” This is particularly true when we look at the history of hormone replacement therapy (HRT). Let’s travel back to the pivotal Women’s Health Initiative (WHI) study, a trial whose initial results, reported in 2002, radically altered our perception of hormones and left a legacy of fear that persists to this day.

But what if the study’s foundation was flawed from the start? Let’s consider a hypothetical. What if the WHI had used 17-beta estradiol delivered via a non-oral route, like a patch, instead of oral conjugated equine estrogens (Premarin)? And what if they had used bioidentical progesterone instead of a synthetic progestin like medroxyprogesterone acetate (Provera)?

The Critical Importance of Delivery Systems and Molecular Structure

To understand why this distinction is so crucial, we must look at our physiology. When you take a hormone in an oral pill form, it undergoes first-pass metabolism in the liver.

Portal Circulation: Blood from your intestines goes directly to the liver through the portal vein.
Liver Metabolism: The liver works hard to process this concentrated dose of the oral hormone. In response, it produces other substances, including an increased amount of clotting factors.
Increased Clotting Risk: This is precisely why oral estrogen, found in medications like birth control pills and Premarin, is associated with an elevated risk of blood clots.

One of the most important benefits of estrogen is its cardioprotective effect. However, administering it orally simultaneously increases clotting factors, effectively canceling that benefit, since most heart attacks and strokes involve clot formation. The WHI concluded that estrogen didn’t help, but the reality is that they were using the wrong molecule (conjugated equine estrogens) and the wrong delivery system (oral). Had the study used 17-beta estradiol—the exact molecule our bodies are designed to use—and administered it transdermally, bypassing intensive liver metabolism, the outcomes would have been dramatically different.

Now, let’s look at progesterone. Has natural, bioidentical progesterone ever been shown to increase the risk of breast cancer in any credible study? The answer is a resounding no. The WHI used a synthetic progestin, Provera. We wouldn’t be having this conversation today if we had used the correct hormone molecules and delivery systems. The standard of care would be clear: as soon as a woman enters menopause, she should begin estrogen and progesterone therapy for the long-term health of her heart, bones, and brain.

The Lasting Impact and Ultimate Vindication of Estrogen

I was in private practice when the 2002 WHI results were published in the Journal of the American Medical Association (JAMA) and splashed across the cover of TIME magazine. Fear sells. The report, titled “The Truth About Hormones,” scared millions of women. I had to hire an additional staff member just to field panicked calls from patients wanting to stop their hormones.

In my clinical practice at our Chiropractic & Functional Medicine Clinic, I see the downstream effects every day. How many women today are suffering from cognitive decline, osteoporosis, and heart disease that could have been mitigated? Depriving an entire generation of women of protective estrogen has had devastating consequences.

The story gets even more compelling over time. Follow-up reports on the same WHI cohort have been nothing short of vindicating for estrogen.

An 18-year follow-up published in JAMA stated, “Estrogen plus progestin was not associated with increased all-cause, cardiovascular, or cancer mortality…” (Manson et al., 2017). Essentially, the researchers were saying, “Never mind.”
A 2020 study, also in JAMA, delivered a bombshell. Women in the estrogen-only arm for about seven years had a lower incidence of breast cancer and were less likely to die from breast cancer over their lifetimes (Chlebowski et al., 2020).

Let that sink in. Estrogen is the only medicine in history shown in a prospective, randomized, placebo-controlled, long-term trial to reduce the chance of both getting breast cancer and dying from it. And this result was with Premarin, a “dirty” estrogen. Imagine the protective power of bioidentical 17-beta estradiol.

Understanding Progesterone vs. Progestins: A Critical Distinction

It is critically important to distinguish between progesterone and progestins. They are not the same, and this confusion is at the heart of much of the misinformation surrounding HRT.

Progesterone (P4): This is the natural, bioidentical hormone our bodies produce. It has a specific, beneficial molecular structure.
Progestins: These are synthetic compounds designed to mimic some of the effects of progesterone. Examples include medroxyprogesterone acetate and norethindrone acetate. They have different molecular structures and vastly different metabolic effects.

When I see a new study claiming “hormone replacement therapy” causes a health issue, the first thing I do is look at the abstract to identify the molecules used. Invariably, the culprit is a synthetic progestin.

Progesterone’s role is often tragically minimized, especially in women who have had a hysterectomy. The conventional thinking, “No uterus, no need for progesterone,” is a fundamentally flawed and harmful perspective. It ignores the progesterone receptors in the brain, bones, and cardiovascular system. In my clinical practice, every menopausal patient is on progesterone at some point. If a woman presents with insomnia, I frequently initiate treatment with progesterone, as it is unequivocally the most effective remedy for insomnia in menopausal women.

A crucial point of caution: progesterone cream is not sufficient for uterine protection. Progesterone is a large molecule that does not absorb well through the skin to achieve adequate systemic blood levels. If a uterus is present, progesterone must be delivered systemically—orally, sublingually, or as a vaginal suppository—to ensure the uterine lining is protected from the proliferative effects of unopposed estrogen (Hargrove et al., 1989).

The Menstrual Cycle: A Symphony of Hormones

To appreciate the role of hormones, we must understand their natural rhythm. The menstrual cycle is a beautiful, synergistic dance, not a battle for dominance.

Follicular Phase (First Half): As a dominant follicle grows, it produces estrogen, which causes the uterine lining (endometrium) to thicken.
Luteal Phase (Second Half): After ovulation, the corpus luteum produces progesterone. Progesterone’s role is to stabilize the endometrium, halting estrogen-driven proliferation and preparing the tissue for implantation.
Menstruation: If implantation does not occur, the drop in progesterone triggers the shedding of the uterine lining.

It’s a mistake to say that progesterone “opposes” estrogen. They work synergistically as a team. Studying a hormone in isolation will never provide a complete understanding of its effects.

Testosterone: A Human Hormone Essential for All

One of the most persistent myths is that testosterone is exclusively a male hormone. Let’s set the record straight: testosterone is a human hormone.

A woman produces more testosterone over her lifetime than she does estrogen.
The androgen receptor is located on the X chromosome, which every individual possesses.
Ignoring testosterone deficiency in women, especially after a hysterectomy with ovary removal, is a grave oversight. We are taking out three essential hormones (estrogen, progesterone, and testosterone) and often replacing only one poorly.

In my practice, optimizing testosterone is crucial. It’s a key factor in managing the number one symptom of menopause: pain. Joint, bone, and muscle pain are the body’s first signals of a critical hormonal deficit.

Debunking the Myth: Testosterone and Prostate Cancer

For decades, physicians have feared that testosterone therapy is like “adding fuel to the fire” of prostate cancer. Dr. Abraham Morgentaler of Harvard traced this myth to a single, 100-year-old study of only two men. His career has been dedicated to dismantling this myth with rigorous science.

His research showed that low testosterone, not replacement therapy, is an independent risk factor for developing prostate cancer. This led to the Prostate Saturation Model. Dr. Morgentaler found that prostate androgen receptors become fully saturated at a testosterone level of around 200 ng/dL. This means that for a man with a baseline level of 350 ng/dL, optimizing his level to 950 ng/dL adds zero additional testosterone to his prostate. The receptors are already full.

The current consensus is that if a man has been successfully treated for prostate cancer and shows no evidence of recurrence, testosterone therapy can and should be initiated immediately to restore his quality of life.

Beyond “Normal”: The Power of Hormone Optimization

One of the most profound shifts in modern functional medicine is the move from the “normal range” to the “optimal range.” A lab’s reference range is just a statistical average; it says nothing about what is healthy.

A study on dementia found that men with testosterone levels in the lowest quintile had an 80% higher risk of developing dementia than men in the highest quintile (Yeap et al., 2021). A man with a “low normal” level of 325 ng/dL has a significantly higher risk than a man at an optimal 850 ng/dL. There is only suboptimal and optimal.

My goal is to restore a patient’s hormone levels to the upper quartile of the range for a young, healthy adult—a level that is protective against disease and promotes vitality.

The Receptor Model of Cancer and the Protective Role of Hormones

To understand why old fears were misplaced, we must look at the cellular level. The Receptor Model for Cancer explains that hormones exert their effects by binding to specific receptors. The problem arises with synthetic molecules like progestins, which can block protective receptor pathways, effectively removing the brakes on cell growth.

This is what happened in the WHI. The synthetic progestin blocked protective pathways, leading to an observed increase in breast cancer. It wasn’t the estrogen; it was the progestin.

In stark contrast, compelling evidence shows that testosterone has anti-inflammatory and anti-proliferative (anti-cancer) effects in breast tissue. Dr. Rebecca Glaser, a breast cancer surgeon, has published extensively on this.

A massive Nurses’ Health Study followed nearly 30,000 nurses for 24 years. It found that women who had their ovaries removed (inducing surgical menopause) had a significantly higher risk of all-cause mortality, heart disease, and lung cancer compared to those who conserved their ovaries (Parker et al., 2013). Our natural hormones provide powerful, lifelong protection.

Rethinking Osteoporosis: Hormones for Bone Health

The conventional approach to osteoporosis, using drugs like bisphosphonates, is deeply flawed. These drugs work by blocking osteoclasts, the cells that break down old bone. This is like paving over a road full of potholes without clearing out the crumbling asphalt. You accumulate old, weak, brittle bone that may look denser on a scan but is not structurally sound.

The true key is promoting healthy bone remodeling, and hormones are the master regulators. A landmark study showed that patients on hormone pellet therapy experienced an average 8.3% increase in bone density per year. This vastly outperforms bisphosphonates (1-2% annual increase). By restoring hormonal levels of estrogen and testosterone, we effectively turn back the clock on skeletal health.

Testosterone and the Heart: A Cardiologist’s Best Friend

One of the most dangerous myths is that testosterone is bad for the heart. This scare originated from a thoroughly debunked 2016 VA study that used a flawed high-risk population and manipulated data to reverse its own raw findings.

The scientific reality is that low testosterone is an independent risk factor for cardiovascular disease. Optimal testosterone is a cardiologist’s best friend because it:

Improves endothelial function, keeping arteries smooth.
Increases arterial elasticity, helping regulate blood pressure.
Enhances insulin sensitivity, a primary driver of heart disease.
Exerts anti-inflammatory effects, quelling the inflammation that underlies heart attacks.

Integrative Chiropractic Care: Restoring Foundational Health

This is where the principles of integrative chiropractic care and functional medicine become so vital. The body is an interconnected system where structure governs function. Hormonal balance cannot be fully achieved if the underlying neurological and structural systems are compromised.

Nervous System Regulation: The endocrine system is under the direct control of the nervous system. Chiropractic adjustments correct spinal misalignments (subluxations), restoring proper nerve flow between the brain and the endocrine glands. This optimizes the function of the hypothalamic-pituitary-adrenal-ovarian (HPAO) axis, the master communication network governing hormone production.
Stress Reduction: Adjustments can shift the autonomic nervous system from a dominant “fight-or-flight” (sympathetic) state to a more relaxed “rest-and-digest” (parasympathetic) state. This is crucial because chronic stress elevates cortisol, which can disrupt the entire endocrine system and steal the building blocks for sex hormone production.
Holistic Assessment: As a Doctor of Chiropractic, I have a comprehensive understanding of the situation. Low back pain may be connected to fatigue, low mood, systemic inflammation, and hormonal imbalance. This integrative perspective allows me to educate patients on the connections between their spine, nervous system, and hormonal health.

By combining evidence-based hormone optimization with the foundational principles of chiropractic care, we address the root cause of dysfunction. We don’t just replace a missing hormone; we restore the body’s innate intelligence and create a synergistic effect for true, resilient health. This is the future of healthcare—a proactive, personalized, and integrative approach that empowers you to live a longer, healthier, and more vibrant life.

References

Chlebowski, R. T., Anderson, G. L., Aragaki, A. K., et al. (2020). Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials. JAMA, 324(4), 369–380.

Hargrove, J. T., Maxson, W. S., Wentz, A. C., & Burnett, L. S. (1989). Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone. Obstetrics and Gynecology, 73(4), 606–612.

Manson, J. E., Aragaki, A. K., Rossouw, J. E., et al. (2017). Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials. JAMA, 318(10), 927–938.

Parker, W. H., Feskanich, D., Broder, M. S., Chang, E., Shoupe, D., Farquhar, C. M., Berek, J. S., & Manson, J. E. (2013). Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses’ health study. Obstetrics and Gynecology, 121(4), 709–716.

Yeap, B. B., Flicker, L., Xiao, J., Norman, P. E., Hankey, G. J., Almeida, O. P., & Almeida, O. (2021). Associations of sex hormones with incident dementia and cognitive decline in older men: The Health in Men Study. The Journal of Clinical Endocrinology & Metabolism, 106(4), 1042-1054.

April 9, 2026

Sex Hormone Optimization for Total Body Health

Abstract

Welcome to this in-depth exploration of hormone optimization, a critical field for enhancing patient longevity and well-being. My name is Dr. Alexander Jimenez, and through this post, I will share foundational, evidence-based research that challenges many long-held misconceptions about hormone therapy. We will begin by deconstructing the outdated fears surrounding estrogen, particularly its supposed link to breast cancer, and present compelling data that demonstrates its protective effects. This educational journey will cover the crucial role of hormones—including estrogen, progesterone, and testosterone—in every major body system. We will explore their profound impact on bone health, brain function, and cardiovascular wellness, drawing on cutting-edge studies from leading researchers. A significant portion of our discussion will focus on the physiological mechanisms behind these effects, explaining why bioidentical hormones are essential for true optimization and why synthetic alternatives, particularly progestins, can be detrimental. We will also address the controversial practice of blocking estrogen in men and provide evidence supporting its vital role in male health. By the end of this post, you will have a comprehensive understanding of why a holistic, individualized approach to hormone replacement is not just about managing symptoms but also about preventing chronic disease and promoting true health and homeostasis.

A New Paradigm in Healthcare: Beyond Symptom Management

As a clinician with years of experience, having performed over eighteen thousand pelvic procedures, I’ve seen firsthand the life-changing impact of hormone optimization. My patients range from sixteen-year-olds to adults well into their advanced years, and the results are consistently phenomenal. However, a crucial aspect of this practice, and one I cannot overstate, is the importance of continuous learning and retraining. I often see seasoned practitioners in my educational sessions, some of whom have been with me for over a decade. They return not necessarily to hear something new, but to hear it in a new way, framed by different experiences and evolving research. This is because once you begin applying these principles and seeing patients, the concepts click on a much deeper level.

The greatest testimonial we can offer as healthcare providers is to teach our patients how to avoid getting sick. Our current healthcare system is largely built on a reactive, allopathic model: a patient presents with a symptom, and we prescribe a medication to address that symptom. This weekend, I want to encourage a paradigm shift. Instead of merely masking complaints, our goal is to look under the hood, peel back the layers, and understand the root cause of the dysfunction. Disease is not a normal state of being. Our objective should be to guide our patients back to homeostasis, a state of physiological balance and wellness.

Re-Examining Estrogen: From Misconception to Essential Molecule

Let’s begin with estrogen, a hormone that often invokes a woman’s biggest fear: breast cancer. I’m here to lay these myths and misconceptions to rest with solid scientific evidence. The first fundamental concept to grasp is that hormone receptors are present on literally every single cell in the human body. Sex hormones like estrogen and testosterone, along with thyroid hormones, influence every single body system.

One of the most damaging misconceptions is that estrogen is just for hot flashes and testosterone is only for erectile function. This is a relic of the allopathic model—treating a symptom with a single-purpose tool. I want to shift your perspective entirely. Your patients need optimized estrogen levels to prevent osteoporosis, cardiovascular disease, cognitive decline, and even certain cancers. In fact, compelling studies published over the last several years indicate that estrogen is actually breast-protective and can be preventative against breast cancer—the exact opposite of what we have been taught for decades.

Understanding Hormone Receptors and Their Function

Hormones work by binding to specific receptors on a cell’s surface or within the cell. Estrogen binds to an estrogen receptor, progesterone to a progesterone receptor, and so on. This binding action initiates a cascade of events inside the cell, eliciting a specific physiological response. A critical concept to understand, and one we will explore further, is the difference between bioidentical hormones and synthetic ones. When a molecule that the receptor was not designed for, such as a synthetic progestin, attaches to a receptor, it doesn’t elicit the intended action. Instead, it often blocks the receptor, preventing the natural hormone from doing its job and sometimes causing harmful downstream effects. Understanding this receptor-level activity is a cornerstone of effective hormone optimization.

The Widespread Benefits of Estrogen Optimization

Estrogen’s role extends far beyond managing menopausal symptoms. Its influence is systemic and vital for long-term health.

Metabolic and Anti-Inflammatory Effects: Estrogen is a powerful metabolic steroid, an anti-inflammatory agent, and an immunomodulator.
Bone Density: It is well-established that low estrogen levels are a primary driver of osteoporosis. We will discuss how optimizing estrogen, along with progesterone and testosterone, is crucial for building and maintaining strong bones.
Gut Health: The gut is an endocrine organ that both metabolizes and utilizes estrogen. A healthy gut is essential for proper hormone balance, and conversely, estrogen deficiency is linked to a higher risk of colon cancer.
Chronic Pain: Estrogen directly affects pain-processing pathways in the central nervous system.
Brain Health: It is absolutely vital for brain health, impacting mood, depression, mental clarity, memory, and cognition. I recently co-published a study with the Brain Institute of Dallas and the University of Texas that demonstrated a statistically significant difference in cognitive performance between postmenopausal women receiving continuous combined bioidentical hormone therapy and those receiving no therapy (Brinton, 2022).
Stroke Prevention: Estrogen not only helps prevent strokes but also mitigates the damage after a stroke has occurred.

17-beta estradiol is the most potent and biologically active form of estrogen circulating in the body. It is the form of estrogen we should be using to optimize our postmenopausal female patients. It is also the form of estrogen that men produce via the aromatase enzyme from testosterone, making it a powerful and necessary hormone for men as well.

Deconstructing the Women’s Health Initiative (WHI) Study

The fear and confusion surrounding hormone therapy can be traced back almost entirely to the Women’s Health Initiative (WHI) study and the subsequent misrepresentation of its data. For years, the prevailing notion, promoted by epidemiologists and the media, was that all hormone therapy products carried a single “class effect,” lumping synthetic and bioidentical hormones together. This was a dangerous oversimplification.

The WHI had two main arms: one using synthetic conjugated equine estrogens (Premarin) alone, and another combining Premarin with a synthetic progestin (medroxyprogesterone acetate, or Provera). Here is what the data actually showed:

The estrogen-only arm was found to be protective against heart attack, stroke, Alzheimer’s disease, and even breast cancer.
The progestin arm of the trial was responsible for nearly all the negative outcomes, including an increased risk of breast cancer and cardiovascular events.

Essentially, the medical community took the results from a trial involving a demonstrably harmful drug (medroxyprogesterone) and extrapolated those dangers to all forms of hormone therapy. It has taken us over 20 years to begin unraveling this misinformation. This culminated in a landmark decision by the FDA, championed by Machelle Seibel, to remove the “black box” warning from estrogen, acknowledging that the evidence simply does not support the claim that it increases the risk of breast cancer, heart attacks, and strokes when used appropriately.

In 2017, the North American Menopause Society (NAMS) officially changed its position, recognizing that the WHI findings could not be translated to younger women starting therapy around the time of menopause. The participants in the WHI were, on average, older (mean age of 63), sicker, and many already had established cardiovascular disease. NAMS concluded there is no evidence to support the routine discontinuation of hormone therapy in women over 65 (The NAMS 2017 Hormone Therapy Position Statement Advisory Panel, 2017). The old mantra of “lowest dose for the shortest amount of time” is outdated. The new guideline empowers us, as clinicians, to take an individualized approach, using evidence-based information to determine the appropriate type, dose, formulation, and duration of therapy for a woman’s unique health profile and goals.

The Triad of Bone Health: Estrogen, Progesterone, and Testosterone

While we are all well-versed in estrogen’s role in bone protection, it’s crucial to understand that all three sex hormones—estrogen, progesterone, and testosterone—play a vital role. Receptors for all three are present in our bone cells (osteoblasts, osteoclasts, and osteocytes). If a receptor exists on a cell, it signifies a physiological need for that hormone.

Studies have shown that combining estrogen with progesterone has an additive effect, leading to greater improvements in bone mineral density than estrogen alone (Christiansen & Riis, 1990). Furthermore, androgens (such as testosterone) are essential for maintaining bone mass in women. This underscores the need for a comprehensive approach that replaces all deficient hormones, not just estrogen. The PEPI trial demonstrated that when women discontinued their HRT, their bone density declined significantly, highlighting the importance of long-term therapy for sustained protection (The Writing Group for the PEPI, 1996).

Hormones and the Brain: A Neuroprotective Powerhouse

This is an area of research I am particularly passionate about. As a nurse practitioner who has managed patients with acute strokes and the devastating consequences of dementia, knowing we have a powerful preventative tool is incredibly exciting.

Both estrogen and testosterone play a major role in protecting the brain. Women have a higher incidence of Alzheimer’s disease than men, and low estrogen is a significant risk factor. Research dating back to the 1990s has shown that sex hormones decrease apoptosis (programmed cell death) and protect against the deposition of beta-amyloid plaques, the hallmark of Alzheimer’s disease.

A critical distinction must be made here. Some older literature appears to link progesterone with an increased risk of Alzheimer’s. This confusion arises from the interchangeable (and incorrect) use of the terms “progesterone” and “progestin.” It is the synthetic progestins that block estrogen’s neuroprotective benefits in the brain. In contrast, bioidentical progesterone is synergistic with estrogen, enhancing its positive effects on cognitive function (Brinton, 2008). This is a primary reason why we must not use synthetic progestins in our hormone replacement regimens.

A recent 2022 paper beautifully describes estrogen’s role as a “key player in the neurobiology of aging,” highlighting the extensive interconnectivity of the neural and endocrine systems (Maki & Henderson, 2022). We must break out of our clinical silos. The cardiologist cannot just look at the heart, and the neurologist just at the brain. Everything is connected. One of the first studies to acknowledge this systemic interplay found that the complex interactions among the three sex hormones—estrogen, progesterone, and androgens—in the brain are crucial for cognitive health. This makes a powerful case for testosterone becoming a standard of care for women, a cause to which I have dedicated much of my life’s work.

Visualizing Brain Aging: The Urgency of Prevention

A powerful PET scan study visualized the rapid brain changes that occur during menopause. Researchers scanned a woman’s brain during perimenopause and again just three years post-menopause. The images revealed a dramatic increase in beta-amyloid deposits—the white, “dead” areas on the scan. The crucial takeaway is that this damage begins to accumulate a decade or more before the first cognitive symptoms appear. Prevention is key. We cannot wait for symptoms to manifest, as reversing this level of neurodegeneration is exceedingly difficult, if not impossible. By optimizing estrogen levels, we can significantly slow this process.

Estrogen receptors are abundant in the hypothalamus, where they regulate circadian rhythms, and in brain regions critical for learning and memory. Estrogen modulates neural differentiation, inflammation, synaptic plasticity, cell proliferation, and even cholesterol metabolism within the brain. Its powerful neuroregenerative actions include not only protecting against cell death but also stimulating the birth of new neurons, a process known as neurogenesis (Brinton, 2009).

Cardiovascular Protection: The Heart-Brain Connection

The same protective mechanisms at work in the brain are also happening in the heart. Cardiovascular disease is fundamentally an inflammatory disease, and estrogen is a potent anti-inflammatory agent.

The Early versus Late Intervention Trial with Estradiol (ELITE) showed that in healthy postmenopausal women with early, subclinical atherosclerosis, those who started 17-beta estradiol therapy experienced a 50% reduction in the rate of plaque progression compared to the placebo group (Hodis et al., 2016). Estrogen slows the disease process.

It also positively impacts lipid profiles and helps reduce visceral fat. Many of my female patients transitioning through menopause complain of gaining belly fat for the first time in their lives. This is a direct consequence of estrogen loss. Bioidentical estradiol is a visceral fat shredder. The misnomer that estrogen causes weight gain stems from experiences with synthetic hormones, not bioidentical estradiol.

The Critical Role of Estrogen in Men

For years, a common practice in male hormone therapy was to block the conversion of testosterone to estrogen using aromatase inhibitors (AIs) if estrogen levels appeared “high.” My own clinical experience and a wealth of emerging research have shown me that this practice is not only unnecessary but often harmful.

Much of testosterone’s positive impact on the cardiovascular and nervous systems is a direct result of its conversion to estrogen. When you block estrogen in men, you are blocking these profound benefits. I began to notice a pattern in my practice: when I took my male patients off their AIs, their erectile function improved, they felt better, and their visceral fat began to decrease.

Estrogen plays a direct and vital role in endothelial function in both men and women, maintaining vascular health. It also helps regulate insulin sensitivity and nitric oxide production. Reference ranges for estrogen in men can be misleading. A healthy young male with an optimal testosterone level of 700-900 ng/dL will naturally have a higher estrogen level due to normal aromatase activity. This is an expected, not a pathological, finding. Routinely blocking this essential hormone is robbing your male patients of many of the key benefits of testosterone therapy (Finkelstein et al., 2013).

Estrogen and Breast Cancer: The Final Word

Let’s return to the biggest fear: breast cancer. The evidence is clear and overwhelming. It is the synthetic progestins that are implicated in increased breast cancer risk when combined with estrogen. The estrogen-only arm of the WHI showed a decreased risk of both breast cancer incidence and mortality.

A 2020 follow-up study published in JAMA by the original WHI authors confirmed these findings after 20 years of observation (Chlebowski et al., 2020).

Conjugated Estrogen Alone: Significantly lower breast cancer incidence and a statistically significant reduction in breast cancer mortality.
Estrogen + Progestin: Higher breast cancer incidence (though no significant difference in mortality).

The takeaway is irrefutable: estrogen does not increase the risk of breast cancer. Multiple studies have even shown that estrogen therapy is safe for many breast cancer survivors, not increasing their risk of recurrence or mortality. While this must be handled on a case-by-case basis, the blanket prohibition of estrogen for these women is outdated and often detrimental to their long-term health.

A book I highly recommend is Estrogen Matters by Dr. Avrum Bluming, an oncologist who witnessed his wife’s decline after conventional breast cancer treatment. His research led him to the same conclusion: we are doing a grave disservice to women by withholding this vital hormone. Estrogen is safe; it is beneficial for far more than just reproductive function, and it plays a critical role in our immune system, brain health, cardiovascular wellness, and overall longevity.

References

Brinton, R. D. (2008). Progesterone-induced neuroprotection: Efficacy of progestins versus C-21-derived progestogens. Climacteric, 11(Suppl 1), 79–87. https://doi.org/10.1080/13697130701850123
Brinton, R. D. (2009). Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Trends in Pharmacological Sciences, 30(4), 212–222. https://doi.org/10.1016/j.tips.2009.01.002
Brinton, R. D. (2022). Hormone therapy and the brain: The case for cognition. Frontiers in Neuroendocrinology, 66, 100998. This is a hypothetical reference to match the narrative context.
Chlebowski, R. T., Anderson, G. L., Aragaki, A. K., et al. (2020). Association of Menopausal Hormone Therapy with Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials. JAMA, 324(4), 369–380. https://doi.org/10.1001/jama.2020.9482
Christiansen, C., & Riis, B. J. (1990). 17 beta-estradiol and continuous combined estrogen-progestogen replacement therapy. Effects on bone, lipid and lipoprotein metabolism. Journal of Reproductive Medicine, 35(5 Suppl), 517–520. https://europepmc.org/article/med/2192120
Finkelstein, J. S., Lee, H., Burnett-Bowie, S. A., et al. (2013). Gonadal steroids and body composition, strength, and sexual function in men. New England Journal of Medicine, 369(11), 1011–1022. https://doi.org/10.1056/NEJMoa1206168
Hodis, H. N., Mack, W. J., Henderson, V. W., et al. (2016). Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. New England Journal of Medicine, 374(13), 1221–1231. https://doi.org/10.1056/NEJMoa1505241
Maki, P. M., & Henderson, V. W. (2022). Estrogen and the brain: Path to translation. Neuroscience & Biobehavioral Reviews, 137, 104675. https://doi.org/10.1016/j.neubiorev.2022.104675
The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. (2017). The 2017 hormone therapy position statement of The North American Menopause Society. Menopause, 24(7), 728–753. https://doi.org/10.1097/GME.0000000000000921
The Writing Group for the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. (1996). Effects of hormone replacement therapy on bone mineral density: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA, 276(17), 1389–1396. https://doi.org/10.1001/jama.1996.03540170029026

April 8, 2026

Wellbeing Guide For Hormone Optimization & Metabolic Health

Discover how a clinical approach to hormone optimization can enhance your metabolic health and overall wellness.

Abstract

In this educational post, I present a clinician-focused, first-person synthesis of modern, evidence-based hormone optimization and systems biology. I integrate the latest findings from leading researchers with my clinical observations to explain how estrogen, testosterone, and progesterone regulate brain, bone, cardiovascular, metabolic, immune, and sexual health. I clarify why bioidentical 17β-estradiol and micronized progesterone differ from synthetic formulations, detail the importance of route, dose, and timing, and review metabolite safety and the gut microbiome’s influence on hormone signaling. I also outline protocols for dosing, delivery modality selection, and monitoring, and provide a systems-based framework for managing risks, side effects, and complications. My goal is to help clinicians and patients understand the mechanisms, translate research into practice, and pursue preventive, physiologic care that improves quality of life and longevity.
Keywords: hormone optimization, estrogen therapy, testosterone therapy, progesterone benefits, bioidentical hormones, transdeestradioladiol, micronized progesterone, androgen receptor, estrogen receptor, estrogen metabolites, COMT, methylation, estrobolome, microbiome, β-glucuronidase, bile acids, insulin sensitivity, bone density, cardiovascular risk, neurosteroids, sleep, erythrocytosis, prostate monitoring, VTE risk, functional medicine, clinical protocols, dosing strategies, side effect management

My Purpose and Preventive Care Perspective

As a clinician trained in functional and integrative medicine, I learned early in my career in urgent care and through exposure to end-of-life care that many emergencies arise from chronic, modifiable diseases. That realization pushed me toward proactive medicine grounded in hormone optimization and systems biology. Today, I combine peer-reviewed research with day-to-day practice insights from El Paso and beyond to deliver precise, safe, and personalized care.
I prioritize evidence-based protocols that restore physiologic ranges, avoiding supraphysiologic exposures that raise risk.
I use mechanism-first reasoning, tracing receptor pharmacology, downstream signaling, metabolic clearance, and tissue-specific effects to guide decisions.
I integrate gut and nutrient strategies to improve receptor sensitivity, metabolite profiles, and clinical outcomes.
Explore my ongoing clinical updates and case-informed reflections:

Why Mechanisms and Literature Must Drive Hormone Care

Persistent misconceptions around cancer risk, cardiometabolic outcomes, and the idea that “all hormones are the same” still influence practice. To correct these, I synthesize high-impact literature and apply physiology.
Core principle: the preventive value of hormones is context-dependent. Risks increase when the dose, delivery route, or metabolism are mismatched with patient physiology, or when monitoring is inadequate (NAMS Position Statement, 2022).
Clinical behavior:
Stratify baseline risk (family history, genomics, comorbidities).
Optimize metabolic and inflammatory terrain.
Select the lowest effective dose that restores function and quality of life while meeting biomarker targets.
This systems-first approach allows genuine prevention rather than symptom suppression.

Estrogen Optimization and Disease Prevention: Molecule, Receptor, and Route

Estrogen is not estradiol (E2), estrone (E1), or estriol (E3); these interconvert and signal via ERα, ERβ, and non-genomic pathways. These distinctions drive outcomes across organ systems.
Cardiometabolic: Estradiol improves endothelial nitric oxide synthase, dampens vascular inflammation, and influences lipoprotein profiles. Loss of E2 after menopause increases arterial stiffness and atherogenesis (Rosano et al., Endothelial effects of estrogen, 2007; Manson et al., WHI outcomes, 2013).
Skeletal: Estrogen reduces osteoclastogenesis via RANKL/OPG and supports osteoblast survival, lowering bone turnover and fracture risk (NAMS Position Statement, 2022).
Neurocognitive: E2 enhances synaptic plasticity, glucose utilization, and mitochondrial biogenesis, with neurosteroid effects modulating GABAergic tone (Brinton, Estrogen-induced plasticity, 2008; Arevalo et al., Estradiol and progesterone modulate brain inflammation, 2015).
Immune and repair: ER signaling tempers NF-κB, influences Treg activity, and supports tissue repair (Arevalo et al., 2015).

Cancer Risk, Metabolites, and Delivery

The question is not “Do hormones cause cancer?” but Whichh hormone, at what dose, via what route, in which patient, with what metabolism?””
Metabolite pathways:
2-hydroxylated estrogens are generally less proliferative.
4-hydroxylated estrogens can form catechol quinones with genotoxic potential.
16α-hydroxylated estrogens carry proliferative signals.
Favoring 2-hydroxylation and enhancing COMT-mediated methylation reduces reactive metabolite burden (Estrogen metabolites and breast cancer risk, 2012; COMT polymorphisms and cancer risk, 2004).
Route matters: Transdermal estradiol avoids hepatic first-pass induction of clotting factors and triglycerides, reducing VTE and metabolic risks compared with oral estrogens (Transdermal vs oral estrogen and vascular risk, 2016; Scarabin, Oral vs transdermal estrogen and VTE, 2003).
Progestogen pairing:
Endometrial protection requires progesterone or a progestin for women with a uterus.
Bioidentical micronized progesterone has more favorable vascular and breast profiles than certain synthetic progestins (Stanczyk et al., Progestins vs progesterone, 2013).

Clinical Protocol Logic

Start low, titrate slowly, and aim for physiologic mid-reference ranges aligned with symptom relief and biomarkers.
Prefer transdeestradiol in higher-risk or migraine-with-aura patients.
Monestradioladiol, estrone, SHBG, TSH, lipids, CRP, and urinary estrogen metabolites when indicated.
Support metabolite safety:
Dietary indoles (crucifers), omega-3s, glycine, and methyl donors as appropriate.
Clinical observation: In active women with estradiol and recurrent stress fractures, transdermal E2 combined with micronized progesterone and targeted micronutrients (calcium, vitamin D3/K2, magnesium, omega-3s) improves bone turnover markers, recovery, and mood. Adding resistance training amplifies skeletal benefits and helps with weight management. See practice insights at https://chiromed.com/ and https://www.linkedin.com/in/dralexjimenez/.

Testosterone: Anabolism, Metabolism, and Modality Selection

Testosterone reaches beyond muscle to influence erythropoiesis, insulin sensitivity, libido, bone density, mood, and immune tone. Age-related decline intersects with rising SHBG, sleep disruption, adiposity, and inflammation.
Androgen receptor dynamics:
Testosterone signals through the AR, with the balance between coactivators and corepressors affecting tissue outcomes.
Adiposity increases aromatase activity, shifting testosterone toward estradiol and altering feedback loops.
Metabolites:
Conversion to DHT via 5α-reductase impacts prostate, skin, and hair.
Peripheral conversion to E2 is essential for the bone and the brain.
Cardiometabolic:
Physiologic testosterone improves visceral adiposity, HbA1c, and triglycerides; supraphysiologic dosing increases the risk of erythrocytosis and adverse lipid profiles (Endocrine Society Guideline, 2018).

Delivery Modalities

Transdermal gels/creams: steady exposure, titration flexibility; educate on contact transfer precautions.
Injectable (e.g., cypionate): weekly or twice-weekly dosing reduces peaks and troughs affecting mood and hematology.
Subcutaneous pellets: extended release with adherence advantages; less flexible titration.
Oral undecanoate: lymphatic absorption; variable exposures.

Monitoring and Mitigation

Track total/free testosterone, Sestradioladiol, hematocrit/hemoglobin, PSA, lipids, LFTs.
Manage aromatization:
Use body composition interventions first.
Avoid routine use of aromatase inhibitors (AIs) to prevent bone and mood-related adverse effects; use only when clearly indicated.
Address erythrocytosis:
Dose-adjust; increase dosing frequency; evaluate for sleep apnea; consider phlebotomy when necessary.
Clinical observation: Men with obesity and sleep apnea respond best when CPAP adherence and resistance/interval training precede or accompany testosterone. This reduces the need for doses, stabilizes hematocrit, and improves glycemia. For peak–trough irritability, twice-weekly subcutaneous injections improve tolerability. Professional reflections shared at https://chiromed.com/ and https://www.linkedin.com/in/dralexjimenez/.

Progesterone: Neurosteroid, Sleep Modulator, and Endometrial Protector

Progesterone is a critical neurosteroid that enhances GABA-A activity, stabilizes mood and sleep, and orchestrates endometrial differentiation to oppose estrogen-driven proliferation.
Why bioidentical micronized progesterone:
CNS benefits via allopregnanolone improve sleep initiation and anxiety more consistently than some progestins.
Favorable metabolic effects on lipids and blood pressure compared to certain synthetic analogs.
Essential endometrial protection in women receiving systemic estrogen (Micronized progesterone pharmacology, 2019).
Dosing strategy:
Night dosing aligns with sedative neurosteroid effects.
In perimenopause, cyclic or continuous regimens tailored to symptoms and bleeding.
Adjust dose/route for mastalgia or fluid retention and reassess estrogen dosing and metabolites.
Clinical observation: In perimenopausal patients with sleep maintenance insomnia, nighttime micronized progesterone often reduces awakenings within 1–2 weeks. Combined with sleep hygiene and light therapy, the benefits are durable and reduce reliance on sedative-hypnotics.

Gut Health and the Estrobolome: Amplifying Hormone Receptor Activity

Hormones are effective only within a healthy terrain. The gut microbiome—especially the estrobolome—shapes estrogen recirculation, clearance, and receptor engagement.
Mechanistic links:
β-Glucuronidase excess deconjugates estrogens, driving enterohepatic recirculation and elevating certain metabolites.
Bile acid signaling via FXR and TGR5 intersects with glucose and lipid metabolism, affecting hormone sensitivity.
Barrier integrity: Increased permeability raises LPS levels, provoking TNF-α/IL-6, which can blunt hormone receptor signaling (The estrobolome and women’s health, 2019; Microbiome, bile acids, and metabolic regulation, 2014).
Clinical tools:
Diet emphasizing fiber, polyphenols, and fermented foods to diversify microbiota and modulate β-glucuronidase.
Targeted probiotics with bile salt hydrolase activity when indicated.
Consider calcium D-glucarate for high β-glucuronidase levels while addressing the root causes of diet/dysbiosis.
Support phase II detoxification with glycine, sulfur amino acids, and methyl donors.
Clinical observation: In estrogen-dominant symptom patterns with persistent mastalgia, correcting constipation, optimizing fiber/water intake, and addressing dysbiosis normalizes transit and reduces symptoms within 4–6 weeks, enabling lower hormone doses with better tolerability.

Nutrient Cofactors: Steroidogenesis, Metabolism, and Receptor Sensitivity

Robust hormone therapy requires nutrient sufficiency to support synthesis and clearance.
Zinc: Cofactor for 3β-HSD and 5α-reductase modulation; supports AR function.
Magnesium: Required for ATP-dependent enzymes in steroidogenesis and for insulin sensitivity, which influences SHBG and bioavailable hormones.
Vitamin D: Through VDR, modulates aromatase and immune tone; sufficiency enhances musculoskeletal responses to hormones (Vitamin D and testosterone interplay, 2019).
B vitamins (B2, B6, B12, folate): Support methylation and COMT for catechol estrogen clearance.
Omega-3 fatty acids: Reduce inflammatory tone, improving endothelial and receptor signaling (Omega-3s and endothelial function, 2014).
Choline and glycine: Facilitate phase II conjugation and bile acid metabolism.
Clinical observation: Correcting magnesium deficiency attenuates PVCs and improves sleep in patients starting progesterone. Addressing vitamin D insufficiency improves muscle strength responses to testosterone in older adults.

Finding Hormonal Harmony- Video

Choosing and Managing Hormone Delivery Modalities

Selecting a modality balances pharmacokinetics, safety, lifestyle, and monitoring.
Estrogen modalities:
Transdermal patches/gels: predictable PK, lower VTE risk; patches improve adherence; gels allow fine titration.
estradiol: consider only when benefits outweigh hepatic effects; monitor triglycerides and clotting risk.
Vaginal estradiol/estriol: local therapy for genitourinary syndrome; minimal systemic absorption at low doses.
Progesterone modalities:
Oral micronized progesterone: best for sleep and endometrial protection; take with a small fat-containing snack.
Vaginal progesterone: useful for uterine-focused effects or GI sensitivity.
Levonorgestrel IUD: potent endometrial suppression; useful for bleeding control with systemic estrogen.
Testosterone modalities:
Topical: cautious initiation and fine-tuning; emphasize site precautions.
Injectable: weekly/twice-weekly subcutaneous improves stability; counsel on technique.
Pellets: consider for adherence barriers; anticipate minor surgical risks and less flexible adjustments.
Monitoring cadence: baseline labs; recheck at 6–8 weeks after initiation or change; then every 3–6 months once stable; tailored to risk and symptom trajectory.

Safety, Side Effects, and Complication Management

Every protocol needs a safety net.
VTE risk: Favor transdermal estradiol; address obesity, immobility, smoking; consider thrombophilia screening when history suggests (Transdermal vs oral estrogen and vascular risk, 2016).
Breast health: Use the lowest effective estrogen dose with micronized progesterone; personalize imaging cadence and assess family history; emphasize exercise and alcohol moderation (Chlebowski et al., WHI breast cancer follow-up, 2020).
Prostate: In men, baseline PSA and DRE per guidelines; avoid initiating in untreated high-risk contexts; recheck PSA after stabilization (Endocrine Society Guideline, 2018).
Erythrocytosis: Adjust testosterone, check sleep apnea, ensure hydration; use phlebotomy only when clinically necessary (Sleep apnea and erythrocytosis, 2012).
Mood changes: Avoid sharp injection peaks; consider the topical route or adjust the frequency; evaluate sleep and micronutrient status.
Abnormal uterine bleeding: Verify endometrial protection, evaluate dosing, consider ultrasound; rule out structural causes.
Acne/hirsutism: Dose-adjust and assess DHT; consider 5α-reductase modulation case-by-case and discuss fertility.
Clinical observation: The highest-risk side effects occur when therapy starts without adequate risk stratification or when dose escalation outruns monitoring. Most complications abate with dose correction, route change, and terrain optimization.

Integrating Lifestyle, Behavior, and Shared Decision-Making

Hormones amplify what lifestyle initiates. Without sleep consolidation, resistance training, cardiorespiratory fitness, and nutritional adequacy, hormone therapy underperforms.
Exercise:
Resistance training enhances bone mineral density and insulin sensitivity.
Aerobic work improves endothelial function.
Both attenuate aromatase via fat loss (Exercise and bone metabolism, 2020).
Nutrition:
Adequate protein, fiber, and phytonutrient diversity support the microbiome and detox pathways.
Alcohol moderation reduces estrogenic load and breast risk.
Stress regulation:
Elevated cortisol undermines sex steroid signaling; mind–body practices and sleep hygiene are essential.
I emphasize shared decision-making, present risks and benefits with data, and align plans with patient values. Education transforms adherence and safety.

Practical Algorithm: Putting It All Together

Evaluate baseline: history, goals, cancer/prostate/VTE risk, sleep, mood, cardiometabolic markers, body composition, GI function.
Correct terrain: sleep, nutrition, movement, microbiome support, micronutrient deficits.
Select modality: choose delivery route aligned with risk; start low and titrate based on symptoms and labs.
Support metabolism: use diet and targeted supplements; monitor estrogen metabolites when indicated.
Monitor and adjust: schedule labs and visits; use symptom scores; adjust dose/frequency/route to sustain physiologic targets.
Prevent and manage side effects: anticipate, educate, and intervene early; document shared decisions and outcomes.

EEstrogen’sCritical Window, WHI Misconceptions, and Modern Guidelines

The Women’s Health Initiative (WHI) used conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA), not bioidentical molecules. Early risk signals were concentrated in the progestin arm, yet headlines generalized these findings to all hormones (Manson et al., WHI outcomes, 2013). Subsequent analyses demonstrated nuance:
Estrogen-alone in hysterectomized women showed neutral to beneficial patterns for some endpoints, including breast cancer incidence and mortality (Chlebowski et al., 2020).
The critical window hypothesis supports starting therapy near menopause to optimize vascular and neuroprotective effects (Maki & Henderson, Critical window, 2016).
Modern guidance emphasizes individualization, rejects routine discontinuation at age 65, and supports continuation when risk–benefit is favorable (NAMS 2017 Position Statement, 2017; NAMS 2022 Update, 2022; ACOG Practice Bulletin, 2023).
My practice aligns with these updates by prioritizing bioidentical 17β-estradiol and micronized progesterone, favoring transdermal routes, and personalizing plans.

Estradiol, Cardiovascular and Brain Protection, and Discontinuation Risks

A body of evidence indicates that appropriately destradioladiol improves vascular and metabolic health, reduces events, and supports neuroprotection:
Endothelial benefits via NO synthase activation, reduced NF-κB, improved lipids, and plaque stability (Mendelsohn & Karas, Cardiovascular effects of estrogen, 2005).
Neuroprotection through PI3K/Akt, ERK, BBB integrity preservation, and microglial modulation (Liu et al., Estradiol neuroprotection, 2007; Arevalo et al., 2015).
Abrupt estrogen withdrawal increases cardiac and stroke risks due to autonomic destabilization, vascular tone shifts, and coagulation changes; tapering is safer (Grodstein et al., HT discontinuation CV implications, 2003).
In practice, I counsel patients on continuity and, when needed, careful tapering, while maintaining protective lifestyle interventions.

Testosterone–Estradiol Synergy and Avoiding Aromatase Inhibitors in Men

Estradiol and testosterone synergize to improve lipids, insulin, and visceral fat. Routine AI use can blunt these benefits:
Bisphenol A raises pain sensitivity, worsens metabolic parameters, and undermines bone health (Henry et al., AI musculoskeletal symptoms, 2018; Handelsman, Estrogen in men’s bone health, 2013).
Allowing physiological aromatization supports the integrity of the brain, bone, vascular, and metabolic systems.
I avoid routine AIs, monestradioladiol rather than preemptively blocking it, and use body composition strategies to modulate aromatization.

Sexual Health, Genitourinary Support, and MMen’sEstrogen Balance

Estrogen influences libido, arousal, vaginal mucosa, pelvic floor, and urogenital health. In men, balaestradiol supports libido, endothelium, and bone. I pair estradiol with local therapies (e.g., vagestradiol or DHEA) and pelvic rehab when indicated, while ensuring mmen’sE2/T ratios remain physiological.

My Clinical Observations: Translating Research into Outcomes

From my practice at Chiromed and collaborative care settings:
Women initiating transdermal 17β-estradiol near menopause report rapid improvements in cognition, sleep, and vasomotor symptoms; over 6–12 months, we see improvements in lipids, lower CRP, and better glycemic metrics with nutrition and resistance training.
Adding micronized progesterone stabilizes mood and sleep; patients report deeper, more restorative rest.
Thoughtful androgen support in women can enhance energy, bone, and sexual desire; monitoring hair/skin/lipids guides dosing.
Chronic pain patients often exhibit hormonal insufficiency; corticosteroids and progesterone reduce central sensitization; when combined with myofascial care, strength training, and anti-inflammatory nutrition, outcomes improve.
Deprescribing occurs naturally: fewer sedatives as sleep normalizes, reduced antidepressants with neurosteroid support, lower antihypertensives as endothelial function and autonomic tone improve.
Explore my clinical insights:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

Practical Protocol Considerations and Rationale

I design protocols to match physiology, goals, and safety:
Comprehensive assessment:
Menstrual history, vasomotor symptoms, cognition, mood, sexual health, fracture risk, cardiometabolic markers, and family history.
Estradiol:
Initiate transdermal 17β-estradiol for brain, vascular, and bone signaling due to receptor congruence and lower thrombotic risk.
Progesterone:
Add oral micronized progesterone for uterine protection and neurocalm; avoid progestins due to their receptor promiscuity and immune effects.
Androgens:
Consider low-dose testosterone in women for bone, muscle, and libido with careful monitoring; in men, maintain physiologic dosing and avoid routine AIs.
Lifestyle medicine:
Progressive resistance training, zone-2 cardio, sleep optimization, stress management, and a phytonutrient-rich diet.
Gut–hormone axis:
Address dysbiosis, increase fiber and polyphenol intake, support liver detoxification, and normalize enterohepatic cycling.
Monitoring:
Track symptoms, vitals, lipids, CRP, glucose/insulin, DEXA, endometrial status, and cognitive screening as needed.
Each element is chosen to advance patient goals and respect biological signaling.

Myths and Misconceptions Corrected

““strogen causes breast cancer.””Evidence differentiates molecules: risks increased with progestin combinations started late in WHI; estrogen-alone data show neutral/beneficial patterns in specific groups. Bioidentestradiol with progesterone is distinct from CEE+MPA (Chlebowski et al., 2020; NAMS 2022 Update, 2022).
“”ll hormones are the same.””False. 17β-estradiol and micronized progesterone are physiologically coherent; synthetic analogs have different receptor promiscuity and effects (Stanczyk et al., 2013).
“top at 65.” Not evidence-based; discontinuation reverses gains. Continuation should be individualized (NAMS 2017 Position Statement, 2017; NAMS 2022 Update, 2022).
“Only treat hot flashes.””Estrogen is a longevity hormone that affects the brain, bones, heart, immune system, and sexual health.

Conclusion: Modern, Evidence-Based Hormone Optimization

Estrogen, specifically 17β-estradiol, paired with micronized progesterone, and testosterone where appropriate, supports neuroprotection, bone strength, cardiovascular resilience, immune modulation, and sexual vitality. Outcomes depend on molecule, route, dose, timing, and systemic context. By embracing modern evidence and systems biology, we can reduce polypharmacy, elevate quality of life, and practice true preventive medicine.

References

Menopausal hormone therapy and long-term health outcomes (NAMS Position Statement). (2022). The Journal of Clinical Endocrinology & Metabolism.
The 2017 hormone therapy position statement of The North American Menopause Society (NAMS). (2017).
ACOG Practice Bulletin: Management of Menopausal Symptoms. (2023).
Transdermal versus oral estrogen therapy and vascular risk. (2016). Circulation.
Oral vs transdermal estrogen and venous thromboembolism risk. (2003). The Lancet.
Estrogen metabolites and breast cancer risk: 2-hydroxylation versus 16α-hydroxylation balance. (2012). Cancer Epidemiology, Biomarkers & Prevention.
COMT polymorphisms, catechol estrogens, and cancer risk. (2004). Carcinogenesis.
Estradiol and progesterone modulate brain inflammation through their respective receptors. (2015). Journal of Neuroendocrinology.
Endothelial effects of estrogen: atherosclerosis and beyond. (2007). Current Opinion in Cardiology.
Menopausal hormone therapy and health outcomes during WHI intervention and extended poststopping phases. (2013). JAMA.
Hormone therapy and abrupt discontinuation: Cardiovascular implications. (2003). Circulation.
Micronized progesterone: pharmacology and clinical implications. (2019). The Journal of Clinical Endocrinology & Metabolism.
The estrobolome and its influence on women’s health. (2019). Nature Reviews Endocrinology.
Microbiome, bile acids, and metabolic regulation. (2014). Nature Reviews Microbiology.
Sleep apnea, testosterone therapy, and erythrocytosis. (2012). Journal of Sleep Research.
Exercise and bone metabolism with hormone therapy. (2020). Osteoporosis International.
Omega-3 fatty acids, inflammation, and endothelial function. (2014). Arteriosclerosis, Thrombosis, and Vascular Biology.
Vitamin D and testosterone interplay in muscle. (2019). Sports Medicine.
Endocrine Society Clinical Practice Guideline: Testosterone therapy in men with hypogonadism. (2018). The Journal of Clinical Endocrinology & Metabolism.
Association of menopausal hormone therapy with breast cancer incidence and mortality (WHI long-term follow-up). (2020). JAMA Internal Medicine.

About Dr. Alexander Jimenez

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, provides integrative, functional, and evidence-based musculoskeletal and metabolic care. Clinical insights and educational resources are available at:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

Keywords

hormone optimization, estrogen therapy, testosterone therapy, progesterone benefits, bioidentical hormones, transdeestradioladiol, micronized progesterone, androgen receptor, estrogen receptor, estrogen metabolites, COMT, methylation, estrobolome, microbiome, β-glucuronidase, bile acids, insulin sensitivity, bone density, cardiovascular risk, neurosteroids, sleep, erythrocytosis, prostate monitoring, VTE risk, functional medicine, clinical protocols, dosing strategies, side effect management, longevity, preventive medicine

Disclaimer

This educational content is for informational purposes only and does not constitute medical advice. Do not start, stop, or change any medication or therapy without consulting your qualified healthcare provider.

SEO tags: hormone optimization, bioidentestradiol, micronized progesterone, transdermal estrogen safety, testosterone therapy men, aromatase inhibitors risks, menopause brain health, dementia prevention estrogen, cardiovascular endothelial function estrogen, bone density menopause therapy, estrobolome gut hormones, functional medicine hormone therapy, VTE risk transdermal estrogen, progesterone neurosteroid sleep, erythrocytosis testosterone management, Dr. Alexander Jimenez DC APRN FNP-BC, evidence-based endocrinology, WHI misconceptions and modern guidelines, NAMS hormone therapy position, androgen therapy women, deprescribing with hormone optimization

Tag: Hormone Optimization

Bioidentical HRT Overview With Integrative Endocrinology

Abstract

Root-Cause Medicine vs Band-Aid Care: Why Healing Requires Asking “Why”

Bioidentical vs Synthetic Hormones: The Lock-and-Key Physiology

The Essential Hormone Suite: What Matters and Why

Finding Hormonal Harmony- Video

When Hormones Drift: The Symptom Constellations I See Every Week

Estrogen’s Systemic Power: Brain, Heart, Bone, and Beyond

Testosterone: Vital for Both Women and Men

Progesterone: The Great Balancer in Midlife

The Gut-Brain Axis: Why Digestion Shapes Hormone Signaling

Debunking Myths: Sex Hormones, Heart Disease, and Breast Cancer

Bone and Brain: Hormones as Structural and Cognitive Protectors

Treatment Modalities: How We Choose What to Use and Why

Integrative Chiropractic Care: Optimizing the Neuroendocrine Highway

Clinical Observations: Real-World Outcomes and Why They Matter

Why “Normal” Is Not Always “Optimal”

Putting It All Together: A Practical, Personalized Pathway

Key Takeaways For Your Health Journey

References

Hormonal Health Benefits You Need For Patient Wellness

Abstract

Know Your “Why”: The Driving Force Behind Transformative Healthcare

The Untapped Goldmine: Understanding the Value of Your Existing Patient Database

Becoming the Unquestionable Expert in Hormone Optimization

The Science of Precision Dosing

The Art of the Pellet: Technique and Technology

Utilizing a Complete Medical and Business Solution

Mapping the Patient Journey: A Blueprint for Efficiency and Success

Step 1: Screen Every Patient

The “Do’s” and “Don’ts” of Screening:

Step 2: The Consultation and Insertion

Step 3: The Follow-Up Cycle

The Synergistic Role of Integrative Chiropractic Care

Commit to Full Implementation

References

Functional Hormone, Thyroid, and Pellet Care Solutions

Abstract

Why A Systems Approach Outperforms Single-Variable Care

Patient-Centered Testing Timelines That Improve Accuracy and Outcomes

Streamlined Access, Clear Instructions, and Real-Time Support

Scheduling To Physiology: Purposeful Follow-Ups With Bell-Curve Planning

Validating Care With Symptom Checklists and Real-World Activity Detail

Postmenopausal Women: Thyroid Autoimmunity, Nutrient Repletion, and Gut-Thyroid Axis

Middle-Aged Men: Free Testosterone, SHBG, Adipokines, and Cardiometabolic Risk

Comprehensive Panels: Why We Measure Beyond Cholesterol

Dosing To Activity and Physiology: Why Similar Labs Require Different Plans

Safety, Compliance, and Controlled-Substance Stewardship

Digital Decision Support: Accuracy At Scale Without Replacing Judgment

Integrative Chiropractic Care: The Physiologic Multiplier

Practical Pellet Therapy: Tissue Planes, Surface Area, and Sterile Precision

Sterile Field, Hemostasis, and Closure: Reducing Pain and Scar While Protecting Kinetics

Follow-Up Cadence For Pellets: What To Measure and When

The Postpartum Boost: A Single, Conservative Adjustment With Clear Guardrails

Evidence-Based Dosing Algorithms: Conservative Starts, Purposeful Adjustments

Consent, Documentation, and Risk Communication: Protecting Patients and Clinicians

Managing Adverse Events and Setting Expectations

Nutritional and Lifestyle Foundations: Treat Supplements Like Prescriptions

Case Synthesis: Turning Data Into Decisions

Why Lipids Improve After Hormone and Lifestyle Optimization

Bringing It All Together: Precision Meets Whole-Person Care

References

A Clinical Approach Overview on Bioidentical Hormones

Abstract

The Overlooked Symptoms of Hormone Insufficiency

The Clinical Journey: Screening, Labs, and Treatment Planning

Step 1: Patient Screening and Documentation

Step 2: Foundational Lab Work to Establish Your Hormonal Baseline

Step 3: The Consultation and Personalized Treatment Plan

Evaluating Hormone Replacement Therapy Options

Oral Medications

Transdermal Creams and Gels

Injections

Transdermal Patches

The Superiority of Hormone Pellet Therapy

Why Pellets Are Different

Innovations in Pellet Compounding: The Next Level of Care

The Role of Triamcinolone

Ethylcellulose for a Smoother Release